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A B S T R A C T
Background
Transfer of more than one embryo during in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) increases multiple pregnancy
rates resulting in an increased risk of maternal and perinatal morbidity. Elective single embryo transfer oIers a means of minimising this
risk, but this potential gain needs to be balanced against the possibility of jeopardising the overall live birth rate (LBR).
Objectives
To evaluate the eIectiveness and safety of diIerent policies for the number of embryos transferred in infertile couples undergoing assisted
reproductive technology cycles.
Search methods
We searched the Cochrane Gynaecology and Fertility Group specialised register of controlled trials, CENTRAL, MEDLINE, Embase,
ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform from inception to March 2020. We
handsearched reference lists of articles and relevant conference proceedings. We also communicated with experts in the field regarding
any additional studies.
Selection criteria
We included randomised controlled trials (RCTs) comparing diIerent policies for the number of embryos transferred following IVF or ICSI
in infertile women. Studies of fresh or frozen and thawed transfer of one to four embryos at cleavage or blastocyst stage were eligible.
Data collection and analysis
Two review authors independently extracted data and assessed trial eligibility and risk of bias. The primary outcomes were LBR and
multiple pregnancy rate. The secondary outcomes were clinical pregnancy and miscarriage rates. We analysed data using risk ratios (RR),
Peto odds ratio (Peto OR) and a fixed eIect model.
Main results
We included 17 RCTs in the review (2505 women). The main limitation was inadequate reporting of study methods and moderate to high
risk of performance bias due to lack of blinding. A majority of the studies had low numbers of participants.
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None of the trials compared repeated single embryo transfer (SET) with multiple embryo transfer. Reported results of multiple embryo
transfer below refer to double embryo transfer.
Repeated single embryo transfer versus multiple embryo transfer in a single cycle
Repeated SET was compared with double embryo transfer (DET) in four studies of cleavage-stage transfer. In these studies the SET group
received either two cycles of fresh SET (one study) or one cycle of fresh SET followed by one frozen SET (three studies). The cumulative live
birth rate aFer repeated SET may be little or no diIerent from the rate aFer one cycle of DET (RR 0.95, 95% CI (confidence interval) 0.82 to
1.10; I2 = 0%; 4 studies, 985 participants; low-quality evidence). This suggests that for a woman with a 42% chance of live birth following
a single cycle of DET, the repeated SET would yield pregnancy rates between 34% and 46%. The multiple pregnancy rate associated with
repeated SET is probably reduced compared to a single cycle of DET (Peto OR 0.13, 95% CI 0.08 to 0.21; I2 = 0%; 4 studies, 985 participants;
moderate-quality evidence). This suggests that for a woman with a 13% risk of multiple pregnancy following a single cycle of DET, the risk
following repeated SET would be between 0% and 3%. The clinical pregnancy rate (RR 0.99, 95% CI 0.87 to 1.12; I2 = 47%; 3 studies, 943
participants; low-quality evidence) aFer repeated SET may be little or no diIerent from the rate aFer one cycle of DET. There may be little
or no diIerence in the miscarriage rate between the two groups.
Single versus multiple embryo transfer in a single cycle
A single cycle of SET was compared with a single cycle of DET in 13 studies, 11 comparing cleavage-stage transfers and three comparing
blastocyst-stage transfers.One study reported both cleavage and blastocyst stage transfers.
Low-quality evidence suggests that the live birth rate per woman may be reduced in women who have SET in comparison with those
who have DET (RR 0.67, 95% CI 0.59 to 0.75; I2 = 0%; 12 studies, 1904 participants; low-quality evidence). Thus, for a woman with a 46%
chance of live birth following a single cycle of DET, the chance following a single cycle of SET would be between 27% and 35%. The multiple
pregnancy rate per woman is probably lower in those who have SET than those who have DET (Peto OR 0.16, 95% CI 0.12 to 0.22; I2 = 0%;
13 studies, 1952 participants; moderate-quality evidence). This suggests that for a woman with a 15% risk of multiple pregnancy following
a single cycle of DET, the risk following a single cycle of SET would be between 2% and 4%. Low-quality evidence suggests that the clinical
pregnancy rate may be lower in women who have SET than in those who have DET (RR 0.70, 95% CI 0.64 to 0.77; I2 = 0%; 10 studies, 1860
participants; low-quality evidence). There may be little or no diIerence in the miscarriage rate between the two groups.
Authors' conclusions
Although DET achieves higher live birth and clinical pregnancy rates per fresh cycle, the evidence suggests that the diIerence in
eIectiveness may be substantially oIset when elective SET is followed by a further transfer of a single embryo in fresh or frozen cycle,
while simultaneously reducing multiple pregnancies, at least among women with a good prognosis.
The quality of evidence was low to moderate primarily due to inadequate reporting of study methods and absence of masking those
delivering, as well as receiving the interventions.
P L A I N   L A N G U A G E   S U M M A R Y
Number of embryos for transfer in women undergoing assisted reproductive technology (ART)
Review question
How many embryos should be transferred in couples undergoing ART?
Background
Multiple pregnancy causes serious health risks for mothers and babies. Single embryo transfer (SET) can reduce the chance of having
twins, triplets or higher order multiples but this needs to be balanced against the risk of lowering the chance of pregnancy or live birth. We
reviewed the evidence about the number of embryos transferred in women undergoing ART. The evidence is current to March 2020.
Study characteristics
We found 17 randomised controlled trials with a total of 2505 participants. Most were not commercially funded. None of the trials compared
repeated single embryo transfer (SET) with multiple embryo transfer. A majority of the studies had low numbers of participants. Reported
results of multiple embryo transfer below refer to double embryo transfer.
Key findings
Repeated single embryo transfer versus multiple embryo transfer in a single cycle
Based on low-quality evidence, there was no indication that overall live birth and clinical pregnancy rates diIered substantially when
repeated SET (either two cycles of single embryo transfer or one cycle of single embryo transfer followed by transfer of a single frozen
embryo) was compared with double embryo transfer (DET). For a woman with a 42% chance of live birth following a single cycle of DET,
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the chance following repeated single embryo transfer would be between 34% and 46%. Moderate-quality evidence suggests that the risk
of multiple birth is much lower in the SET group (between 0% and 3%) compared to a 13% chance of multiple pregnancy following a single
cycle of DET. The chance of miscarriage rate is similar between the two groups.
Single versus multiple embryo transfer in a single cycle
We found low-quality evidence that the rates of live birth and clinical pregnancy (CPR) were lower aFer one cycle of fresh SET compared
with the outcome of one cycle of fresh DET. For a woman with a 46% chance of live birth following one cycle of DET, the chance following
one cycle of SET was between 27% and 35%. However, the risk of multiple pregnancy was higher aFer DET. There was no diIerence in the
chance of miscarriage between the two groups.
Conclusion
While live birth and clinical pregnancy was lower following SET compared to DET aFer single fresh cycle, there was no diIerence between
overall live birth rate and CPR following consecutive SET versus a single cycle of DET. However, the multiple pregnancy rate is much lower
following SET compared to DET. Most of the evidence currently available concerns younger women with a good prognosis.
Quality of evidence
The quality of evidence was low to moderate primarily due to inadequate reporting of study methods and absence of masking those
delivering, as well as receiving the interventions.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Repeated single embryo transfer (mixed policies) versus multiple embryo transfer in a single cycle of IVF or ICSI
Repeated single embryo transfer (mixed policies) versus multiple embryo transfer in a single cycle of IVF or ICSI
Patient or population: transfer following in vitro fertilisation or intracytoplasmic sperm injection
Setting: clinic
Intervention: repeated single (mixed policies)
Comparison: multiple embryo transfer
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pooled 127 per 1000 18 per 1000
(11 to 30)
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(432 to 556) (0.84 to 1.08) (3 RCTs)
Miscarriage
rate










*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1 Very serious risk of bias, downgraded by 2 levels: high risk or unclear risk of bias for allocation concealment, high risk of bias for performance bias due to lack of blinding.
2 Serious risk of indirectness, downgraded by 1 level: single centre study.
3 Serious risk of bias, downgraded by 1 level: high risk or unclear risk of bias for allocation concealment. We did not downgrade for performance bias as it is unlikely, that any
change in clinician's behaviour due to knowledge of group allotment will influence outcomes such as multiple pregnancy or miscarriage rates.
4 Serious risk of imprecision, downgraded by 1 level: wide confidence interval.
 
 
Summary of findings 2.   Single compared to multiple embryo transfer in a single cycle following IVF or ICSI
Single compared to multiple embryo transfer in a single cycle following in vitro fertilisation or intracytoplasmic sperm injection
Patient or population: transfer following in vitro fertilisation or intracytoplasmic sperm injection
Setting: clinic
Intervention: single embryo transfer
Comparison: multiple embryo transfer (in a single cycle)
Anticipated absolute effects* (95% CI)Outcomes






























































































































































































Miscarriage rate 72 per 1000 69 per 1000
(46 to 99)







*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1 Very serious risk of bias, downgraded by 2 levels: unclear or high risk for allocation concealment, high risk for performance bias due to lack of blinding in majority of the included
studies.
2 Serious risk of bias, downgraded by 1 level: high risk or unclear risk of bias for allocation concealment. We did not downgrade for performance bias as it is unlikely, that any
change in clinician's behaviour due to knowledge of group allotment will influence outcomes such as multiple pregnancy or miscarriage rates.
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B A C K G R O U N D
Description of the condition
Historically, in an eIort to achieve 'acceptable' pregnancy
rates, most women undergoing in vitro fertilisation (IVF) and
intracytoplasmic sperm injection (ICSI) have received transfer of
multiple embryos. This practice results in high rates of multiple
pregnancy, however, leading to poor clinical outcomes for the
mother, her children or both (ASRM 2012).
In the 1990s it was calculated that women undergoing assisted
reproductive technology (ART) had an approximately 20-fold
increased risk of twins and 400-fold increased risk of higher
order pregnancies (Martin 1998). In 2014, twins accounted for
nearly 17% of all live births resulting from ART in Europe (De
Geyter 2018). Widespread concern about the medical, social and
economic consequences of multiple pregnancy has prompted the
development of strategies aimed at promoting birth of a single
healthy baby following ART (ESHRE 2000).
Compared with singleton births, twins have a four-fold increased
risk of perinatal mortality, and for triplets the risk is increased
six-fold (ESHRE 2000). An earlier study of 50,258 births following
IVF and ICSI pregnancies reported that twins accounted for half
the total neonatal deaths and one-third of the perinatal deaths
(Sullivan 2012). Twins had a significantly higher perinatal mortality
rate compared to singletons (27.8 per 1000 births and 12.4 per 1000
births, respectively). The relatively high congenital malformation
rates observed in babies born aFer IVF and ICSI are attributed to
the high proportion of multiple births in this population (Sebire
2000 [pers comm]; Wennerholm 2000). In babies with very low
birth weight, twin gestation is an independent risk factor for
neurodevelopmental impairment including cerebral palsy, severe
bilateral hearing loss and bilateral blindness (Wadhawan 2009).
Twin pregnancy also increases the risk of obstetric complications,
with a high incidence of miscarriage, pregnancy-induced
hypertension, gestational diabetes, premature labour and
abnormal delivery (FIVNAT 1995; ESHRE 2000). AFer the initial sense
of achievement of parenthood, the care of children from a multiple
gestation is oFen associated with practical diIiculties and high
stress levels (Garel 1992; Doyle 1996; Garel 1997). More hours per
week are required to care for six-month-old triplets and to carry
out the necessary household tasks. Even in families with material
resources and plenty of help, emotional stress is not uncommon
and may necessitate psychiatric help (Garel 1997).
The economic impact of multiple pregnancies on health services
is another consideration. In an Australian study, the average cost
of ART twin delivery was almost three times as high as for an
ART singleton, while for higher order multiple births the cost was
up to 11 times greater (Chambers 2007). It has been suggested
that redeployment of money saved by reduction of multiple
pregnancies could allow for increased provision of ART treatment
in the UK at no extra cost (Ledger 2006).
Description of the intervention
IVF or ICSI is followed by the transfer of one or multiple (usually
between two to four) fresh or frozen and thawed embryos within
the uterine cavity. Surplus embryos can be frozen and transferred
in a subsequent natural or hormone-stimulated transfer cycle.
There is a worldwide trend for an increase in the rates of elective
single embryo transfer, defined as the transfer of a single embryo,
chosen from a larger number of available embryos, at cleavage
or blastocyst stage. In Europe in 2014, about 35% of all embryo
transfers were of single embryos but much higher rates are
reported in some countries (80% in Sweden in 2014, and 89% in
Australia and New Zealand in 2017) (Australia New Zealand ART
data 2017; De Geyter 2018).
Embryos are oFen transferred aFer culture for two or three
days, when they contain two to eight cells (cleavage stage). The
rationale for cleavage-stage transfer is that the uterus is the best
environment for the survival of the embryo (Laverge 2001). Over
the past decade there has been a shiF in practice to the transfer
of embryos on day five or six, when they have developed into
blastocysts. Blastocyst transfer has been shown to be successful
(Papanikolaou 2006; Khalaf 2008); it requires laboratory expertise
and experience in extended embryo culture. An advantage of
blastocyst transfer is that embryos surviving five days are more
likely to be viable than embryos at two or three days, and so the
likelihood of implantation is higher. Disadvantages of blastocyst
transfer include a higher risk of cycles being cancelled (Marek 1999);
and fewer embryos being available for cryopreservation due to
arrested embryo progression.
A Cochrane Review comparing cleavage-stage versus blastocyst
transfer reported that blastocyst transfer was associated with a
small but significant increase in the live birth rate per couple
(Glujovsky 2016). There was no significant diIerence between the
cleavage versus blastocyst stage in rates per couple of cumulative
pregnancy following fresh and frozen-thawed transfer aFer one
oocyte retrieval. Multiple birth rates did not diIer between the two
groups.
How the intervention might work
A strategy of reducing the risk of multiple pregnancy by limiting the
number of embryos transferred needs to be balanced against the
risk of jeopardising the overall pregnancy rate. An obvious solution
is to consider an individualised embryo transfer policy based on
identification of key clinical and laboratory parameters associated
with a higher implantation rate.
A study from Germany found no significant diIerence in pregnancy
rates following elective transfer of two and three embryos (22% vs.
22.5%) (Ludwig 2000). The multiple pregnancy rates were 16.1%
and 24% following two and three embryos transfer, respectively. In
a study which used a donor oocyte recipient model, the pregnancy
rates (57.8% vs. 55.8%) were comparable following transfer of
two and three embryos (Licciardi 2001). The multiple pregnancy
rates were 40.5% and 51% following two and three embryos,
respectively.
Use of elective single embryo transfer at the cleavage stage (day
two or three) has been limited in clinical practice for fear that the
overall success rates of ART would decline. This assumption has
been supported by the published results of single embryo transfer
where only one embryo was available. Because no opportunity
for selection of more suitable embryos exists, the implantation
potential of the only available embryo is usually poor, with clinical
pregnancy rates of around 10% (FIVNAT 1995; Giorgetti 1995;
Preutthipan 1996; Yaron 1997; Lieberman 1998; Westergaard 2000).
In a situation where the transferred embryos are the only available
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embryos, pregnancy rates are unfavourable even for multiple
embryo transfer (Ludwig 2000).
A study from Finland reported a 20.2% pregnancy rate in 94 women
who had only one embryo available for transfer compared with a
rate of 29.7% in women who had multiple embryos available and
from which a single high-quality embryo was selected for transfer.
The cumulative pregnancy rate aFer frozen and thawed embryo
transfers in the elective single embryo transfer group was 47.3%
per oocyte retrieval. By comparison, the pregnancy rate for double
embryo transfers was 29.4% per transfer, of which 23.9% were twin
pregnancies (Vilska 1999).
Another strategy for reducing multiple pregnancy is multifetal
pregnancy reduction. However, this procedure is invasive; can
have long term adverse psychological consequences for the
potential parents (Berkowits 1996; McKinney 1996); and may be
unacceptable to some couples given the attendant ethical and legal
issues.
Why it is important to do this review
The National Institute for Health and Care Excellence (NICE)
guidelines recommend single embryo transfer (SET) for women
aged less than 37 years and no more than two embryos for
women aged 37 and beyond (NICE 2013). The American Society
of Reproductive Medicine (ASRM) recommends single embryo
transfer for women aged less than 38 years and not more than three
embryos for women aged 38 to 40 years (ASRM 2017).
In an individual patient data meta-analysis, authors reported
significantly lower live birth rate following fresh elective SET (eSET)
compared to double embryo transfer (DET), but the cumulative
live births were comparable (McLernon 2010). Similar findings
were reported by another systematic review which compared SET
versus DET at cleavage stage (Gelbaya 2010). However, success
of eSET policy depends on good and reliable cryopreservation
programme. Clinicians in Europe have generally accepted the
desirability of reducing multiple births by limiting the number of
embryos transferred, especially if this can be achieved without
unduly reducing live birth rates (Roberts 2011). It is important to
find ways to limit the risk of multiple pregnancy without reducing
the chance of achieving live birth in couples undergoing ART cycles.
This updated systematic review evaluates the eIectiveness and
safety of diIerent policies for the number of embryos transferred in
couples who undergo ART.
O B J E C T I V E S
To evaluate the eIectiveness and safety of diIerent policies for
the number of embryos transferred in infertile couples undergoing
assisted reproductive technology cycles.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Published and unpublished randomised controlled trials (RCTs)
were eligible for inclusion. We excluded non-randomised studies
(for example studies with evidence of inadequate sequence
generation such as alternate days, chart numbers) as they are
associated with a high risk of bias. Cross-over trials were eligible but
we planned that only data from the first phase would be included
in the meta-analysis as the cross-over design is not valid in this
context.
Types of participants
Women who underwent embryo transfer following IVF or ICSI
treatment for female or male infertility with their own gametes or
as oocyte or embryo donation recipients were eligible for inclusion.
Types of interventions
We compared the following interventions.
1. Repeated single embryo transfer versus repeated multiple
embryo transfer
2. Repeated single embryo transfer (mixed policies) versus
multiple embryo transfer in a single cycle
3. Single versus multiple embryo transfer in a single cycle
4. Double embryo transfer versus more than two embryos
transferred
5. Other fresh or frozen cycle comparisons
Mixed policies covered diIerent SET strategies such as two fresh
cycles of SET or a single fresh SET followed by transfer of a single
frozen embryo in a natural or hormone-stimulated cycle.
It was required that elective transfer of embryos followed an initial
fresh IVF or ICSI treatment using standard protocols for controlled
ovarian stimulation, oocyte retrieval under ultrasound guidance,
insemination, embryo culture, and transcervical replacement of
embryos (cleavage stage or blastocyst) using standard culture
medium and catheters for the culture and transfer of embryos
respectively.
Studies could (in addition) transfer one or more frozen-thawed
embryos in one or both arms using standard procedures in a natural
or hormone-stimulated cycle.
We excluded studies comparing cleavage-stage transfer versus
blastocyst-stage transfer.
Types of outcome measures
Primary outcome
(1) EIectiveness: live birth rate per woman or couple, or cumulative
live birth rate per woman or couple (in trials with multiple transfers
or multiple cycles).
We defined live birth as delivery of a live foetus aFer 20 completed
weeks of gestational age (duration of pregnancy). We counted
the delivery of single, twin, or multiple pregnancies as one live
birth. Cumulative live birth rate reflects the number of live births
following fresh and frozen embryo transfers aFer a single ART
treatment leading to oocyte collection, or (where stated) aFer
multiple ART cycles. It is calculated by dividing the total number of
live births in each group by the total number of women randomised
in each group. One ART cycle is defined as a single treatment
leading to oocyte collection and a fresh embryo transfer or a frozen
embryo transfer (where fresh embryo transfer was not performed).
(2) Safety: multiple pregnancy rate per woman or couple. The
demonstration of more than one sac with a fetal pole on ultrasound
scan defines a multiple pregnancy.
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Secondary outcomes
(1) EIectiveness: clinical pregnancy rate per woman or couple.
We defined clinical pregnancy as the presence of a gestational sac
on ultrasound scan or confirmation of products of conception by
pathological examination in the event of spontaneous miscarriage
or ectopic pregnancy.
(2) Safety: miscarriage rate per woman. Miscarriage rate per
randomised woman, defined as the spontaneous loss of a clinical
pregnancy that occurs before 20 completed weeks of gestation.
Search methods for identification of studies
We searched for all relevant published and unpublished RCTs
without language restriction and in consultation with the Cochrane
Gynaecology and Fertility Group (CGFG) Information Specialist.
Electronic searches
We searched the following electronic databases:
• The CGFG's specialised register of controlled trials; searched 16
March 2020, PROCITE platform (Appendix 1);
• Cochrane Central Register of Studies Online (CENTRAL CRSO);
searched 16 March 2020, Web platform (Appendix 2);
• MEDLINE; searched from 1946 to 16 March 2020, OVID platform
(Appendix 3);
• Embase; searched from 1980 to 16 March 2020, OVID platform
(Appendix 4);
• PsycINFO; searched from 1806 to 16 March 2020, OVID platform
(Appendix 5);
• CINAHL; searched from 1961 to 16 March 2020, EBSCO platform
(Appendix 6).
The MEDLINE search was limited by the Cochrane Highly Sensitive
Search Strategy filter for identifying randomised trials, which
appears in the Cochrane Handbook of Systematic Reviews of
Interventions (Version 5.1.0, Chapter 6, 6.4.11) (Higgins 2011). We
combined the Embase (OVID platform only) searches with a trial
filter developed by the Scottish Intercollegiate Guidelines Network
(SIGN) (https://www.sign.ac.uk/what-we-do/methodology/search-
filters/).
Other electronic sources of trials included the following.
• Trials registers for ongoing and registered trials.
* www.ClinicalTrials.gov;
* www.who.int/trialsearch/Default.aspx
• OpenGrey for unpublished literature from Europe at
www.opengrey.eu.
• Citation index: Web of Science.
Searching other resources
We handsearched other resources as follows.
• Conference proceedings: International Federation of Fertility
Societies (IFFS), American Society for Reproductive Medicine
(ASRM), British Fertility Society (BFS), European Society of
Human Reproduction and Embryology (ESHRE) between 1997
and 2020
• Bibliographies of the identified studies
We personally communicated with experts and investigators in the
field to get information on newly planned studies and information
on existing embryo transfer policies.
Data collection and analysis
Selection of studies
At least two review authors (including MM and MSK) independently
selected trials for inclusion in the review from those identified
by the search strategy. They resolved disagreements about study
eligibility by discussion with a third author (SB).
Data extraction and management
Three review authors (MM, MSK and RK) independently performed
quality assessment and data extraction. They invited the senior
review author (SB) to resolve any disagreements by discussion.
They sought additional information on trial methodology or trial
data from the principal authors of trials which appeared to meet
the eligibility criteria but were unclear in aspects of methodology,
or where the data were in a form unsuitable for meta-analysis.
Assessment of risk of bias in included studies
We assessed the included studies for risk of bias using the Cochrane
'Risk of bias' tool to evaluate the following: random sequence
generation; allocation concealment; blinding of participants,
providers and outcome assessors; completeness of outcome data;
selective outcome reporting; and other potential sources of bias. At
least three authors (MM, MSK and RK) assessed these six domains.
They resolved any disagreements by consensus or by discussion
with another author (SB). The assessments are presented in the
'Risk of bias' tables (see Characteristics of included studies).
Measures of treatment e<ect
All data were dichotomous. We used the numbers of events in
the control and intervention groups of each study to calculate the
Mantel-Haenszel risk ratios (RRs) with 95% confidence intervals
(CIs). We used Peto odds ratios for outcomes with low event rates.
Where outcome data were reported as a percentage of the total
number of participants, we included them in the analyses by
multiplying the percentage by the total number of participants (n)
in that group and dividing by 100.
Unit of analysis issues
The primary analysis was per woman randomised; we included per
pregnancy data for the outcome 'miscarriage'. We counted multiple
live births (for example twins or triplets) as one live birth event. We
planned to include only first-phase data from cross-over trials. We
did not include 'per cycle' data in tables of comparison but reported
them descriptively.
Dealing with missing data
We analysed the data on an intention-to-treat basis as far as
possible and made attempts to obtain missing data from the
original investigators by contacting them by email. We sent
reminder emails when we did not get any response to the initial
email. We assumed live births or clinical pregnancies would not
have occurred in women without a reported outcome.
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Assessment of heterogeneity
The authors considered whether the clinical and methodological
characteristics of the included studies were suIiciently similar
for meta-analysis to provide a meaningful summary. Clinical
heterogeneity in subfertility (such as variations in entry criteria and
subtle diIerences in the treatment used that are important from a
clinical aspect) cannot be avoided because most centres use their
own protocols which can vary in some aspects. When trials met
the inclusion criteria and had performed the same intervention
we considered it appropriate to pool their results. Statistical
heterogeneity was assessed by inspecting the scatter in the data
points and the overlap in their CIs and, more formally, by checking
the results of the I2 statistic. We took an I2 measurement greater
than 50% to indicate substantial heterogeneity (Higgins 2011).
If we detected substantial heterogeneity, we explored possible
explanations in sensitivity analyses. Even when included trials in
a comparison group were statistically homogeneous, there were
potentially considerable diIerences in clinical features (clinical
heterogeneity). We took these diIerences into account when
analysing and interpreting the pooled results.
Assessment of reporting biases
In view of the diIiculty of detecting and correcting for publication
bias and other reporting biases, we aimed to minimise their
potential impact by ensuring a comprehensive search for eligible
studies and by being alert for duplication of data. If there
were suIicient studies (preferably more than 10) for the primary
outcomes, we planned to use a funnel plot to explore the possibility
of small-study eIects (a tendency for estimates of the intervention
eIect to be more beneficial in smaller studies).
Data synthesis
We combined the data from primary studies using Review Manager
5 (RevMan 5) soFware to calculate pooled Mantel-Haenszel RRs
and 95% CIs, using a fixed-eIect model, with the following
comparisons.
1. Repeated single embryo transfer versus repeated multiple
embryo transfer
2. Repeated single embryo transfer (mixed policies) versus
multiple embryo transfer in a single cycle
3. Single versus multiple embryo transfer in a single cycle
4. Double embryo transfer versus more than two embryos
transferred
5. Other fresh or frozen cycle comparisons
We stratified data by the stage of embryo transfer (cleavage or
blastocyst).
We reformatted the comparisons of interest, as above. The choice
of repeated single versus repeated multiple embryo transfer as
the first comparison of interest reflects the view that a policy
of repeated SET may optimise the chance of live birth while
minimising the risk of multiple pregnancy (Roberts 2011).
An increase in the odds of a particular outcome, which may be
beneficial (for example live birth) or detrimental (for example
multiple pregnancy) is displayed graphically in the meta-analyses
to the right of the centre line and a decrease in the odds of an
outcome to the leF of the centre-line.
Subgroup analysis and investigation of heterogeneity
If data were available, we planned to conduct subgroup analyses
to determine the separate evidence within groups for diIerent
prognostic characteristics.
We planned subgroup analysis for the following prognostic factor.
• Cleavage stage versus blastocyst stage transfer
If we detected substantial heterogeneity, we planned to explore
possible explanations in sensitivity analyses. We planned to take
any statistical heterogeneity into account when interpreting the
results.
Sensitivity analysis
We conducted sensitivity analyses for the primary outcomes
to determine whether the conclusions were robust to arbitrary
decisions made regarding study eligibility and statistical methods.
We considered whether the review conclusions would have diIered
if: 
1. eligibility had been restricted to studies without high or unclear
risk of bias in any domain;
2. a random-eIects model had been adopted;
3. the summary eIect measure had been odds risk rather than
relative risk ratio.
Overall quality of the body of evidence: 'Summary of findings'
table
We generated 'Summary of findings' tables using GRADEPro
soFware and Cochrane methods (GRADEpro GDT; Higgins 2011).
These tables evaluated the overall quality of the body of evidence
for the primary review outcomes for selected comparisons: these
were 'Repeated single compared to mixed policies for transfer
following in vitro fertilisation or intracytoplasmic sperm injection'
and 'Single compared to multiple (in a single cycle) for transfer
following in vitro fertilisation or intracytoplasmic sperm injection'.
Items assessed were study limitations (that is risk of bias),
consistency of eIect, imprecision, indirectness and publication
bias. We incorporated judgements about evidence certainty (high,
moderate or low) into the reporting of results.
We have used the methods and recommendations described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011), employing GRADEpro GDT soFware (GRADEpro GDT). We
have justified all decisions to down- or upgrade the certainty of
evidence using footnotes and have made comments to aid reader's
understanding of the review where necessary. Two review authors
have independently made decisions about evidence quality, and
have resolved any disagreements by discussion.
We included the following outcomes in the 'Summary of findings'
tables.
1. Live birth rate per woman randomised
2. Multiple pregnancy rate per woman randomised
3. Clinical pregnancy per woman randomised
4. Miscarriage rate per woman randomised
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R E S U L T S
Description of studies
Results of the search
The search for the previous 2013 update identified 640 articles
(including duplicates). Five new studies were included in the
previous 2013 update (ASSETT 2003; Gardner 2004; Thurin 2005;
ECOSSE 2006; Prados 2015); these were added to the seven studies
in the earlier 2009 update (Vauthier-Brouzes 1994; Gerris 1999;
Martikainen 2001; Thurin 2004; Lukassen 2005; Heijnen 2006; van
Montfoort 2006). Six studies were excluded (Motta 1998 A & B;
Livingstone 2001; Bowman 2004; Elgindy 2011; Guerif 2011; Forman
2012). In addition, two studies excluded from the previous 2009
version of the review were included (Komori 2004; Mostajeran
2006). Finally, 14 trials were included in the previous 2013 update
(Vauthier-Brouzes 1994; Gerris 1999; Martikainen 2001; ASSETT
2003; Gardner 2004; Komori 2004; Thurin 2004; Lukassen 2005;
Thurin 2005; ECOSSE 2006; Heijnen 2006; Mostajeran 2006; van
Montfoort 2006; Prados 2015). One of the included studies was
unpublished data; this is now published in a peer-reviewed journal
(Prados 2015). One study which was awaiting classification in the
earlier update was published and is now among included studies
for the current update (Clua 2015). Of the two ongoing studies in
the previous update, one is completed and we have included it in
the current update (Abuzeid 2017); and we have excluded the other
completed study (Forman 2012).
2020: the targeted update search resulted in 2230 records. AFer
removing 973 duplicates, we screened a total of 1257 records.
Two reviewers independently examined the titles and abstracts
and identified 30 records as potentially eligible, and obtained
the full text for examination. Among these 30 records, we found
two records from a previously excluded study—Forman 2012—
and therefore excluded them. We excluded two records arising
from Thurin 2009 which had earlier appeared as a companion
paper along with one of the included studies—Thurin 2004—in
the previous version. We excluded 18 records from 16 studies
(Eijkemans 2006; Harrild 2009; Forman 2013; SchoolcraF 2013;
Forman 2014; López-Regalado 2014a; Bensdorp 2015; Zhang 2015;
Brabers 2016; Hatırnaz 2016; Rodriguez 2016; Yang 2016; Lao 2017;
van Loendersloot 2017; IRCT20141217020351N10; NCT03758833).
Two of these excluded studies had a main paper and a companion
paper (Bensdorp 2015; Zhang 2015). One of the records was from an
included study in the earlier update (Mostajeran 2006). One of the
records was the main paper of a study which was already included
in the previous update (published as a conference abstract) (Prados
2015). Finally, we included three new studies (six records; one study
had a main paper, abstract paper and clinical trial registry record;
one more study had a main paper and clinical trial registry record)
(López-Regalado 2014b; Clua 2015; Abuzeid 2017).
For details, see Figure 1.
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Figure 1.   Study flow diagram.
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Figure 1.   (Continued)
 
Included studies
For this update, we added three studies to the 14 included in
the earlier update, making a total of 17 included studies. We
sought additional information from authors of all the new trials and
replies were received from three (López-Regalado 2014b; Clua 2015;
Abuzeid 2017).
See the 'Characteristics of included studies' table.
Study design and setting
We included 17 studies with a total of 2505 participants in the
review (Vauthier-Brouzes 1994; Gerris 1999; Martikainen 2001;
ASSETT 2003; Gardner 2004; Komori 2004; Thurin 2004; Lukassen
2005; Thurin 2005; ECOSSE 2006; Heijnen 2006; Mostajeran 2006;
van Montfoort 2006; López-Regalado 2014b; Clua 2015; Prados
2015; Abuzeid 2017). All were randomised parallel-group trials. Six
were multicentre (Martikainen 2001; ASSETT 2003; Thurin 2004;
Thurin 2005; ECOSSE 2006; Heijnen 2006). Sample sizes ranged
from 23 to 661 women.
Of the four unpublished studies that we have added to the
previous update, one was a pilot trial published as part of a PhD
dissertation (Thurin 2005). Another, the 'Australian study of single
embryo transfer', was stopped early because its implementation
immediately and substantially altered consumer decision making:
this had the eIect of more than tripling rates of elective single
embryo transfer during the study period and reducing study
participation rates (M Davies, University of Adelaide, personal
communication) (ASSETT 2003). A UK trial, known as the 'EIicacy
and cost eIectiveness of selective single embryo transfer' (ECOSSE)
study, was also stopped early due to poor recruitment (ECOSSE
2006). The fourth unpublished study was finally published and we
have included it in the current update (Prados 2015).
Eleven studies reported their funding sources. Seven reported
non-commercial funding (Gerris 1999; ASSETT 2003; ECOSSE 2006;
Mostajeran 2006; van Montfoort 2006; López-Regalado 2014b;
Prados 2015); and four reported pharmaceutical company funding
(Gardner 2004; Thurin 2004; Thurin 2005; Abuzeid 2017).
Participants
Study inclusion criteria diIered with regard to participant age. Most
studies had a maximum age threshold. This varied across studies
and included 34 years (Gerris 1999), 35 years (Vauthier-Brouzes
1994; Lukassen 2005; Abuzeid 2017), 36 years (Thurin 2004), 38
years (ECOSSE 2006; López-Regalado 2014b; Prados 2015), and 40
years (ASSETT 2003). One study included women aged between 38
and 45 years (Heijnen 2006); while another required them to be
at least 36 years old (Thurin 2005). Other studies used a variety
of age limits (Martikainen 2001; van Montfoort 2006). One of the
studies included oocyte donation cycles only and recipients' ages
were between 18 and 50 years (Clua 2015).
Two studies only included women in their first treatment cycle
(Gerris 1999; van Montfoort 2006); while four included women with
an indication for IVF or ICSI either for the first time or aFer a
previous successful treatment (Vauthier-Brouzes 1994; Lukassen
2005; Heijnen 2006; López-Regalado 2014b). Five studies included
women in their first or second IVF or ICSI treatment cycle (ASSETT
2003; Thurin 2004; Thurin 2005; Clua 2015; Abuzeid 2017). In
a multicentre study, one centre included women in their first
treatment cycle only and another centre included women in
their first or second cycle (Martikainen 2001). One study included
all women undergoing IVF and embryo transfer who agreed to
participate (Gardner 2004).
The duration of infertility was mentioned in eight studies (Gerris
1999; Thurin 2004; Lukassen 2005; Thurin 2005; Heijnen 2006;
van Montfoort 2006; López-Regalado 2014b; Abuzeid 2017); and
nine mentioned the indication(s) for treatment (Martikainen 2001;
Thurin 2004; Lukassen 2005; Thurin 2005; Heijnen 2006; Mostajeran
2006; van Montfoort 2006; López-Regalado 2014b; Abuzeid 2017).
See 'Prognostic factors' in Table 1.
Two studies did not provide details of participant characteristics
(Komori 2004; Mostajeran 2006).
Interventions
All the studies included embryo transfer aFer fresh IVF or ICSI
cycles; and three studies included frozen cycles administered to
one or both groups (Thurin 2004; Thurin 2005; López-Regalado
2014b). Several other studies also administered frozen cycles
during follow-up but not as part of the randomised comparison
(Vauthier-Brouzes 1994; Martikainen 2001; ECOSSE 2006; Prados
2015; Clua 2015; Abuzeid 2017).
Interventions in the included studies were as follows.
• One fresh single embryo transfer (SET) plus one frozen embryo
transfer (1FET) in a natural or hormone-stimulated cycle
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compared with one fresh cycle of double embryo transfer (DET)
(Thurin 2004; Thurin 2005; López-Regalado 2014b)
• Two fresh cycles of SET compared with one fresh cycle of DET
(Lukassen 2005)
• One fresh cycle of SET plus multiple cycles of frozen DET
compared with one cycle of fresh DET plus multiple cycles of
frozen DET (ECOSSE 2006)
• One fresh cycle of SET compared with one fresh cycle of DET
(Gerris 1999; Martikainen 2001; ASSETT 2003; Gardner 2004; van
Montfoort 2006; Clua 2015; Prados 2015; Abuzeid 2017)
• One fresh cycle of DET compared with one fresh cycle of triple
embryo transfer (TET) (Heijnen 2006);
• Fresh or frozen DET compared with fresh or frozen TET, multiple
cycles (Komori 2004)
• Two fresh cycles of DET compared to two fresh cycles of TET
(Heijnen 2006)
• Three fresh cycles of DET compared to three fresh cycles of TET
(Heijnen 2006)
• Fresh DET compared with fresh TET where the number of cycles
used was unclear (Mostajeran 2006)
• One fresh cycle of DET compared with one fresh cycle of four
embryo transfer (FET) (Vauthier-Brouzes 1994)
One study reported only 'per cycle' data (Komori 2004). There was
a large disparity between the number of women (169) and the
number of cycles (212), and it was unclear how many women were
included in each group. The data from this study were therefore
unusable.
Four studies that randomised women to more than one embryo
transfer cycle reported interim data aFer the first fresh cycle of
SET versus DET (Thurin 2004; Lukassen 2005; Thurin 2005; ECOSSE
2006). In the case of ECOSSE 2006, these were the only data
available, as the trial was stopped due to poor recruitment and data
were only available for the first cycle (i.e. fresh DET versus fresh
SET).
Protocols for ovarian stimulation, oocyte recovery and embryo
transfer were clearly described in 12 studies (Vauthier-Brouzes
1994; Gerris 1999; Martikainen 2001; Thurin 2004; Lukassen 2005;
Thurin 2005; Heijnen 2006; van Montfoort 2006; López-Regalado
2014b; Clua 2015; Prados 2015; Abuzeid 2017). Good-quality
embryos were transferred in all studies, usually at cleavage
stage. However, in four studies all or some women had embryos
transferred at blastocyst rather than cleavage stage; this applied
to a small number of women in two studies (Thurin 2004; Thurin
2005), half the women in one study (Prados 2015), and all women
in another study (Gardner 2004). The stage of embryo transfer was
not mentioned in one study (Mostajeran 2006).
Natural progesterone was used for luteal phase support in most
cases (Gerris 1999; Martikainen 2001; Gardner 2004; Thurin 2004;
Lukassen 2005; Thurin 2005; Heijnen 2006; van Montfoort 2006;
Clua 2015; Prados 2015; Abuzeid 2017). One study used both human
chorionic gonadotropin (HCG) and natural progesterone for luteal
phase support (Vauthier-Brouzes 1994).
Outcomes
Primary outcomes
1. Live birth rate and cumulative live birth rate
Fourteen studies reported live birth rate per couple (Vauthier-
Brouzes 1994; Gerris 1999; Martikainen 2001; ASSETT 2003; Thurin
2004; Lukassen 2005; Thurin 2005; ECOSSE 2006; Heijnen 2006;
van Montfoort 2006; López-Regalado 2014b; Clua 2015; Prados
2015; Abuzeid 2017). One reported 'take home baby' per cycle only
(Komori 2004).
Six studies reported cumulative live birth rates (ASSETT 2003;
Thurin 2004; Lukassen 2005; Thurin 2005; Heijnen 2006; López-
Regalado 2014b).
2. Multiple pregnancy rate per woman or couple
All but one study reported multiple pregnancy rate per couple. One
reported multiple pregnancy per cycle only (Komori 2004).
Secondary outcomes
1. Clinical pregnancy rate
Thirteen studies reported pregnancy rate per couple (Vauthier-
Brouzes 1994; Gerris 1999; Martikainen 2001; Gardner 2004; Thurin
2004; Lukassen 2005; Heijnen 2006; Mostajeran 2006; van Montfoort
2006; López-Regalado 2014b; Prados 2015; Clua 2015; Abuzeid
2017).
2. Miscarriage rate per woman
Six studies reported miscarriage rate (Martikainen 2001; Lukassen
2005; van Montfoort 2006; López-Regalado 2014b; Clua 2015;
Abuzeid 2017).
Excluded studies
See Characteristics of excluded studies.
We excluded 31 studies from the review for the following reasons.
• Seven studies were not randomised (Bowman 2004; van
Montfoort 2005; Moustafa 2008; Guerif 2011; López-Regalado
2014a; Hatırnaz 2016; Lao 2017).
• Eighteen studies did not report a comparison of interest
(Staessen 1993; Gardner 1998; Motta 1998 A & B; Livingstone
2001; Frattarelli 2003; Levitas 2004; Pantos 2004; Heijnen
2007; Thurin 2009; Elgindy 2011; Forman 2012; Forman
2013; Forman 2014; Bensdorp 2015; Zhang 2015; Yang 2016;
IRCT20141217020351N10; NCT03758833).
• Six studies were reviews, costs analysis and methodological
studies (Eijkemans 2006; Harrild 2009; SchoolcraF 2013; Brabers
2016; Rodriguez 2016; van Loendersloot 2017).
Risk of bias in included studies
See Characteristics of included studies; Figure 2; Figure 3.
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Figure 2.   Methodological quality graph: review authors' judgements about each methodological quality item
presented as percentages across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment (detection bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
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Figure 3.   Methodological quality summary: review authors' judgements about each methodological quality item





























































































































































Abuzeid 2017 + + - + + + -
ASSETT 2003 + + + + + + ?
Clua 2015 + + - + + + ?
ECOSSE 2006 + + + + + + ?
Gardner 2004 + ? - + ? ? ?
Gerris 1999 + ? - + + + ?
Heijnen 2006 + + - + + + +
Komori 2004 ? ? - + ? ? ?
López-Regalado 2014b + - - + + + +
Lukassen 2005 + ? - + + + +
Martikainen 2001 + ? - + + + ?
Mostajeran 2006 ? ? - + - ? ?
Prados 2015 + + - + + + -
Thurin 2004 + ? + + + + ?
Thurin 2005 + ? + + + + ?
van Montfoort 2006 ? ? + + + + ?
Vauthier-Brouzes 1994 ? ? - + ? + ?
 
Allocation
Generation of random sequence
Thirteen studies were at low risk of bias related to random
sequence generation (Gerris 1999; Martikainen 2001; ASSETT 2003;
Gardner 2004; Thurin 2004; Lukassen 2005; Thurin 2005; ECOSSE
2006; Heijnen 2006; Lopez 2014a; Clua 2015; Prados 2015; Abuzeid
2017). Four studies did not describe their randomisation methods
and were therefore at unclear risk of this bias (Vauthier-Brouzes
1994; Komori 2004; Mostajeran 2006; van Montfoort 2006).
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Allocation concealment
Six studies were at low risk of bias related to allocation
concealment. They used sealed opaque envelopes (ASSETT 2003;
Abuzeid 2017),remote allocation (ECOSSE 2006; Heijnen 2006;
Prados 2015) or used concealed allocation created by statistical
unit (Clua 2015). In the other 10 studies a satisfactory method of
allocation concealment was not described clearly enough or no
information was given, and we therefore rated the risk of this bias
as unclear (Gerris 1999; Martikainen 2001; ASSETT 2003; Gardner
2004; Thurin 2004; Lukassen 2005; Thurin 2005; Lopez 2014a; Clua
2015; Abuzeid 2017). One study was considered to be at high risk for
selection bias since the embryologist had access to randomisation
numbers (Lopez 2014a).
Blinding
We rated five trials at low risk of performance and detection bias
related to blinding, as neither the patient nor physician knew
whether one embryo or two embryos had been transferred (ASSETT
2003; Thurin 2004; Thurin 2005; ECOSSE 2006; van Montfoort 2006).
Four studies were unblinded (Lukassen 2005; Prados 2015; Clua
2015; Abuzeid 2017); and the others did not mention blinding. We
rated these 12 studies at high risk of performance bias as lack
of blinding could potentially influence clinicians behaviour and
aIect outcomes such as live birth and clinical pregnancy rates
(Vauthier-Brouzes 1994; Gerris 1999; Martikainen 2001; Gardner
2004; Komori 2004; Lukassen 2005; Heijnen 2006; Mostajeran 2006;
López-Regalado 2014b; Prados 2015; Clua 2015; Abuzeid 2017).
However, we categorised these 12 studies as low risk of detection
bias since all the outcomes were objective in nature.
Incomplete outcome data
We rated 12 studies as at low risk of this bias as they included
all randomised women in the analysis (Gerris 1999; Martikainen
2001; ASSETT 2003; Thurin 2004; Lukassen 2005; Thurin 2005;
ECOSSE 2006; Heijnen 2006; van Montfoort 2006; Lopez 2014a;
Clua 2015; Prados 2015). We also categorised another study at
low risk for attrition bias as authors reported withdrawal of only
one randomised women among 50 randomised in the intervention
group (n = 49 in intervention group versus n = 50 in control group)
(Abuzeid 2017). We rated three studies as at unclear risk of this
bias because it was unclear how many women were included in
the analysis (Vauthier-Brouzes 1994; Gardner 2004; Komori 2004).
We rated one study at high risk of this bias because it was unclear
how many women were randomised: women non-compliant with
the drug regimen or who had ovarian hyperstimulation syndrome
(numbers not stated) were excluded and three women with ectopic
pregnancy were also excluded from the analysis (Mostajeran 2006) .
Selective reporting
We judged 14 studies to be at low risk of this bias. We deemed three
studies to be at unclear risk of this bias: two studies that did not
report live birth (Gardner 2004; Mostajeran 2006); and one study
which only reported 'per cycle' data (Komori 2004).
Other potential sources of bias
We judged three studies to be at low risk of other potential biases
(Heijnen 2006; López-Regalado 2014b; Lukassen 2005); and 12 at
unclear risk. We deemed two studies to be at high risk for other
sources of bias (Prados 2015; Abuzeid 2017). One study gave women
the option of changing the number of embryos transferred or the
day of transfer if they were unhappy with the group to which they
were randomised (Prados 2015). A large number of participants
(21%) chose to change, including 36% of women in the SET groups
who changed to DET. Although the study was analysed by 'intention
to treat', the results were deemed to be at high risk of bias due
to the high level of non-compliance and the fact that nearly all
the changes were in the same direction. In another study, the
proportion of top-quality blastocysts were significantly higher in
one group (Abuzeid 2017). This could potentially influence the
outcomes and we categorised the study to be at high risk for other
potential source of bias. Further, the planned sample size was 200
(according to trial registry information), but only 100 women were
randomised.
E<ects of interventions
See: Summary of findings 1 Repeated single embryo transfer
(mixed policies) versus multiple embryo transfer in a single cycle
of IVF or ICSI; Summary of findings 2 Single compared to multiple
embryo transfer in a single cycle following IVF or ICSI
The results below are formatted by type of comparison, as follows.
1. Repeated single embryo transfer versus repeated multiple
embryo transfer
2. Repeated single embryo transfer (mixed policies) versus
multiple embryo transfer in a single cycle
3. Single versus multiple embryos transfer in a single cycle
4. Double embryo transfer versus more than two embryos
transferred
5. Other fresh or frozen cycle comparisons
1. Repeated single embryo transfer versus repeated multiple
embryo transfer.
No studies compared repeated single embryo transfer versus
repeated multiple transfer.
2. Repeated single embryo transfer (mixed policies) versus
multiple embryo transfer in single cycle
Four studies, all of cleavage-stage transfer, made this comparison
(Thurin 2004; Thurin 2005; Lukassen 2005; Lopez 2014a).
Specific interventions were as follows (with the number of cycles in
brackets).
• Single embryo transfer (×2) versus double embryo transfer (×1)
(SET (×2) versus DET (×1)) (Lukassen 2005).
• Single embryo transfer (×1) plus transfer of one frozen-thawed
embryo in a natural or hormone-stimulated cycle versus double
embryo transfer (×1) (SET + 1 FET versus DET (×1)) (Thurin 2004;
Thurin 2005; Lopez 2014a).
Primary outcomes
2.1 Cumulative live birth rate
When we pooled the four studies, the cumulative live birth rate aFer
repeated single embryo transfer may be little or no diIerent from
the rate aFer one cycle of DET (RR 0.95, 95% CI 0.82 to 1.10; I2 = 0%; 4
studies, 985 women; low-quality evidence) (Thurin 2004; Lukassen
2005; Thurin 2005; Lopez 2014a). This suggests that for a woman
with a 42% chance of live birth following a single cycle of DET, the
chance following repeated SET would be between 34% and 46%.
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Sensitivity analysis
There were no studies which were at low risk of bias for the
outcome. The overall findings did not materially change with the
use of a random-eIects model rather than a fixed-eIect model or
with use of odds ratio rather than risk ratio.
2.1.1 SET + 1 FET versus DET (×1)
Three studies reported cumulative live birth rates aFer SET
followed by 1 FET versus DET in a single cycle (Thurin 2004;
Thurin 2005; Lopez 2014a). There may be little or no diIerence in
cumulative live birth rates following SET + 1 FET versus DET (RR
0.93, 95% CI 0.79 to 1.09; I2 = 0%; 3 studies, 878 women; low-quality
evidence).
2.1.2 SET (×2) versus DET (×1)
A single study compared cumulative live birth rate aFer two fresh
cycles of SET versus a single fresh cycle of DET (Lukassen 2005). We
are uncertain whether cumulative live birth rate improves following
two fresh cycles of SET compared to single fresh cycle of DET (RR
1.14, 95% CI 0.70 to 1.84; 1 study, 107 women; very low quality
evidence).
See Analysis 2.1; Figure 4
 
Figure 4.   Forest plot of comparison: 2 Repeated SET (mixed policies) versus multiple ET in a single cycle, outcome:
2.1 Cumulative live birth.
Study or Subgroup






Heterogeneity: Chi² = 1.39, df = 2 (P = 0.50); I² = 0%
Test for overall effect: Z = 0.90 (P = 0.37)





Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 1.96, df = 3 (P = 0.58); I² = 0%
Test for overall effect: Z = 0.68 (P = 0.50)
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(1) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5
(2) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5)
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)
(F) Selective reporting (reporting bias)
(G) Other bias
 
2.2 Multiple pregnancy rate
When the four studies were pooled, the multiple pregnancy rate
aFer repeated single embryo transfer probably reduces compared
to a single cycle of DET (Peto odds ratio (OR) 0.13, 95% CI 0.08 to
0.21; I2 = 0%; 4 studies, 985 women; moderate-quality evidence)
(Thurin 2004; Lukassen 2005; Thurin 2005; Lopez 2014a). This
suggests that for a woman with a 13% risk of multiple pregnancy
following a single cycle of DET, the risk following repeated SET
would be between 0% and 3%.
Sensitivity analysis
There were no studies which were at low risk of bias for the
outcome.
2.2.1 SET + 1 FET versus DET (×1)
Three studies reported multiple pregnancy rates aFer SET plus 1
FET versus DET in a single cycle (Thurin 2004; Thurin 2005; Lopez
2014a). The multiple pregnancy rate probably reduces following
SET + 1 FET versus DET (Peto OR 0.13, 95% CI 0.08 to 0.22; I2 = 0%; 3
studies, 878 women; moderate-quality evidence).
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
2.2.2 SET (×2) versus DET (×1)
A single study compared the multiple pregnancy rate aFer two fresh
cycles of SET versus a single fresh cycle of DET (Lukassen 2005). We
are uncertain whether multiple pregnancy rate reduces following
two fresh SET compared to single cycle of DET (Peto OR 0.12, 95%
CI 0.03 to 0.54; 1 study, 107 women; very low quality evidence).
See Analysis 2.2; Figure 5
 
Figure 5.   Forest plot of comparison: 2 Repeated SET (mixed policies) versus multiple ET in a single cycle, outcome:
2.2 Multiple pregnancy.
Study or Subgroup






Heterogeneity: Chi² = 0.01, df = 2 (P = 1.00); I² = 0%
Test for overall effect: Z = 7.54 (P < 0.00001)





Test for overall effect: Z = 2.75 (P = 0.006)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 0.02, df = 3 (P = 1.00); I² = 0%
Test for overall effect: Z = 8.03 (P < 0.00001)
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(1) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5
(2) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5)
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)




2.3 Clinical pregnancy rate
When data from the three studies reporting this outcome were
pooled, the clinical pregnancy rate aFer repeated single embryo
transfer appeared to be little or no diIerent from the rate aFer
one cycle of DET (RR 0.99, 95% CI 0.87 to 1.12; I2 = 47%; 3
studies, 943 women; low-quality evidence) (Thurin 2004; Lukassen
2005; Lopez 2014a). This suggests that for a woman with a 51%
chance of clinical pregnancy following a single cycle of DET, the
corresponding chance following repeated SET would be between
43% and 56%.
2.3.1 SET + 1 FET versus DET (×1)
Two studies reported the clinical pregnancy rate aFer SET followed
by 1 FET versus DET in a single cycle (Thurin 2004; Lopez 2014a).
We found no diIerence between the groups (RR 0.97 95% CI 0.84
to 1.11; I2 = 65%; 2 studies, 836 women). Substantial heterogeneity
was noted with no obvious explanation.
2.3.2 Fresh SET (×2) versus DET (×1)
A single study compared the clinical pregnancy rate aFer two fresh
cycles of SET versus a single fresh cycle of DET and did not find a
diIerence between the two groups (RR 1.18, 95% CI 0.81 to 1.71; 1
study, 107 women) (Lukassen 2005).
See Analysis 2.3
2.4 Miscarriage rate per woman randomised
Two studies reported the miscarriage rate aFer two cycles of SET
versus a single fresh cycle of DET (Lukassen 2005; Lopez 2014a). The
miscarriage rate aFer repeated episodes of single embryo transfer
may be little or no diIerent from the rate aFer one cycle of DET
(Peto OR 2.14, 95% CI 0.93 to 4.95; I2 = 0%; 2 studies, 282 women;
low-quality evidence). This suggests that for a woman with a 8%
chance of miscarriage following a single cycle of DET, the chance
following repeated SET would be between 7% and 29%.
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There was no diIerence in miscarriage rate per pregnancy between
the two groups (Peto OR 1.87, 95% CI 0.77 to 4.53).
2.4.1 SET + 1 FET versus DET (×1)
No diIerence in miscarriage rate was found aFer SET followed by 1
FET versus DET in a single fresh cycle (Lopez 2014a) (Peto OR 2.86,
95% CI 0.85 to 9.67; 1 study, 175 women). There was no diIerence in
miscarriage rate per pregnancy between the two groups (Peto OR
2.46, 95% CI 0.70 to 8.68).
2.4.2 Fresh SET (×2) versus DET (×1)
No diIerence in miscarriage rate was found following two fresh SET
versus DET (Lukassen 2005) (Peto OR 1.65, 95% CI 0.52 to 5.23; 1
study, 107 women). There was no diIerence in miscarriage rate per
pregnancy between the two groups (Peto OR 1.44, 95% CI 0.42 to
4.96).
See Analysis 2.4.
3. Single versus multiple embryo transfer in a single cycle
Eleven studies of cleavage-stage transfer made this comparison
(Gerris 1999; Martikainen 2001; ASSETT 2003; Thurin 2004;
Lukassen 2005; Thurin 2005; ECOSSE 2006; van Montfoort 2006;
Lopez 2014a; Clua 2015; Prados 2015); as did three of blastocyst-
stage transfer (Abuzeid 2017; Gardner 2004; Prados 2015). One
study reported both cleavage and blastocyst stage transfers (Prados
2015).
All compared one cycle of single versus one cycle of double embryo
transfer (SET (×1) versus DET (×1)). As noted above, for five of these
studies the data for this comparison derive from an interim analysis,
as women in one or both arms were randomised to undergo further
transfer cycles if the first cycle did not result in pregnancy (Thurin
2004; Thurin 2005; Lukassen 2005; ECOSSE 2006; Lopez 2014a).
However, the two new studies in the update did not randomise
women in two groups following an unsuccessful cycle and all
women underwent DET in a subsequent cycle, hence we included
only the data from first treatment cycle in the pooled analysis
(Abuzeid 2017; Clua 2015).
Primary outcomes
3.1 Live birth rate
Eleven studies of cleavage-stage transfer and two of blastocyst
transfer reported this outcome. See Analysis 3.1; Figure 6.
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Figure 6.   Forest plot of comparison: 2 Single versus multiple (in a single cycle), outcome: 2.1 Live birth.
Study or Subgroup














Heterogeneity: Chi² = 6.43, df = 10 (P = 0.78); I² = 0%
Test for overall effect: Z = 6.13 (P < 0.00001)





Heterogeneity: Chi² = 0.16, df = 1 (P = 0.69); I² = 0%
Test for overall effect: Z = 3.31 (P = 0.0009)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 6.64, df = 12 (P = 0.88); I² = 0%
Test for overall effect: Z = 6.89 (P < 0.00001)
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(1) Study included only oocyte donation cycles
(2) Interim analysis from (planned) multi-cycle study.
(3) Interim analysis from multi-cycle study.
(4) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5. Interim analysis from multi-cycle study.
(5) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5). Interim analysis from multi-cycle study.
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)
(F) Selective reporting (reporting bias)
(G) Other bias
 
When we pooled all studies, low-quality evidence suggests that the
live birth rate per woman may reduce in women who had SET than
those who had DET (RR 0.67, 95% CI 0.59 to 0.75; I2 = 0%; 12 studies,
1904 women; low-quality evidence). This suggests that for a woman
with a 46% chance of live birth following a single cycle of DET, the
chance following a single cycle of SET would be between 27% and
35%.
Sensitivity analysis
There were no studies which were at low risk of bias for the
outcome. The overall findings did not materially change with the
use of a random-eIects model rather than a fixed-eIect model or
with use of odds ratio rather than risk ratio.
Subgroup analysis
We performed subgroup analysis according to stage of transfer
(cleavage versus blastocyst stage). It showed no evidence between
the subgroups ‒ test for subgroup diIerences: Chi2 = 0.04, df = 1 (P
= 0.85), I2 = 0%.
3.1.1 SET (×1) versus DET (×1) cleavage stage
These findings applied in comparisons of cleavage-stage transfer
(RR 0.67, 95% CI 0.59 to 0.76; I2 = 0%; 11 studies, 1704 women).
3.1.2 SET (×1) versus DET (×1) blastocyst stage
These findings also applied in the comparison of blastocyst transfer
(RR 0.65, 95% CI 0.51 to 0.84; I2 = 0%; 2 studies, 200 women).
A funnel plot for this outcome was not suggestive of publication
bias. See Figure 7
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Figure 7.   Funnel plot of comparison: 3 Single versus multiple (in a single cycle), outcome: 3.1 Live birth.










SET (x1) versus DET (x1) (cleavage stage) SET (x1) versus DET (x1) (blastocyst stage)
 
3.2 Multiple pregnancy rate
Eleven studies of cleavage-stage transfer and three of blastocyst
transfer reported this outcome. See Analysis 3.2; Figure 8.
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Figure 8.   Forest plot of comparison: 2 Single versus multiple (in a single cycle), outcome: 2.2 Multiple pregnancy.
Study or Subgroup














Heterogeneity: Chi² = 6.27, df = 10 (P = 0.79); I² = 0%
Test for overall effect: Z = 10.04 (P < 0.00001)






Heterogeneity: Chi² = 4.75, df = 2 (P = 0.09); I² = 58%
Test for overall effect: Z = 4.72 (P < 0.00001)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 11.11, df = 13 (P = 0.60); I² = 0%
Test for overall effect: Z = 11.09 (P < 0.00001)
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(1) Study included only oocyte donation cycles
(2) Interim analysis from (planned) multi-cycle study.
(3) Interim analysis from multi-cycle study.
(4) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5.Interim analysis from multi-cycle study.
(5) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5).Interim analysis from multi-cycle study.
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)
(F) Selective reporting (reporting bias)
(G) Other bias
 
When we pooled all studies, moderate-quality evidence suggests
the multiple pregnancy rate per woman probably reduces in those
who had SET than those who had DET (Peto OR 0.16, 95% CI 0.12 to
0.22; I2 = 0%; 13 studies, 1952 women; moderate-quality evidence).
This suggests that for a woman with a 15% risk of multiple
pregnancy following a single cycle of DET, the risk following a single
cycle of SET would be between 2% and 4%.
Sensitivity analysis
There were no studies which were at low risk of bias for the
outcome.
Subgroup analysis
We performed subgroup analysis according to stage of transfer
(cleavage versus blastocyst stage). It showed no evidence between
the subgroups ‒ test for subgroup diIerences: Chi2 = 0.09, df = 1 (P
= 0.77), I2 = 0%.
3.2.1 SET (×1) versus DET (×1) cleavage stage
These findings applied in comparisons of cleavage-stage transfer
(Peto OR 0.16, 95% CI 0.11 to 0.22; I2 = 0%; 11 studies, 1704 women).
3.2.2 SET (×1) versus DET (×1) blastocyst stage
These findings also applied in comparisons of blastocyst transfer
(Peto OR 0.18, 95% CI 0.09 to 0.36; I2 = 58%; 3 studies, 248 women).
Heterogeneity in this subgroup analysis appeared to derive from a
study at high risk of bias (Prados 2015). Treatment contamination
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(also known as ‘cross-over’) occurred in a high proportion of cases
in this study and would be expected to attenuate any treatment
diIerence. I2 reduced to 0% when this study was excluded from the
analyses, without materially aIecting the conclusion.
Secondary outcomes
3.3 Clinical pregnancy rate
Eight studies of cleavage-stage transfer and three of blastocyst
transfer reported this outcome. See Analysis 3.3
When we pooled 10 studies, low-quality evidence suggests that the
clinical pregnancy rate per woman may reduce in women who had
SET than those who had DET (RR 0.70, 95% CI 0.64 to 0.77; I2 = 0%; 10
studies, 1860 women; low-quality evidence). This suggests that for
a woman with a 55% chance of clinical pregnancy following a single
cycle of DET, the chance following repeated SET would be between
35% and 42%.
Subgroup analysis
We performed subgroup analysis according to stage of transfer
(cleavage versus blastocyst stage). It showed no evidence between
the subgroups ‒ test for subgroup diIerences: Chi2 = 0.36, df = 1 (P
= 0.55), I2 = 0%.
3.3.1 SET (×1) versus DET (×1) cleavage stage
These findings applied in comparisons of cleavage-stage transfer
(RR 0.69, 95% CI 0.62 to 0.78; I2 = 19%; 8 studies, 1612 women).
3.3.2 SET (×1) versus DET (×1) blastocyst stage
These findings also applied in comparisons of blastocyst transfer
(RR 0.74, 95% CI 0.62 to 0.88; I2 = 0%; 3 studies, 248 women).
3.4. Miscarriage rate per woman randomised
Six studies of cleavage-stage transfer and one of blastocyst transfer
reported this outcomes. See Analysis 3.4.
When seven studies were pooled, there may be little or no
diIerence in the miscarriage rate per women between those who
had SET and those who had DET (Peto OR 0.96, 95% CI 0.66 to 1.42; I2
= 27%; 7 studies, 1560 women; low-quality evidence). This suggests
that for a woman with a 7% chance of miscarriage following a single
cycle of DET, the chance following repeated SET would be between
4% and 10%.
The miscarriage rate per pregnancy was higher in SET group
compared to DET group (Peto OR 1.62, 95% CI 1.07 to 2.47).
Subgroup analysis
We performed subgroup analysis according to stage of transfer
(cleavage versus blastocyst stage). It showed no evidence between
the subgroups ‒ test for subgroup diIerences: Chi2 = 0.00, df = 1 (P
= 0.96), I2 = 0%.
3.4.1 SET (×1) versus DET (×1) cleavage stage
Six studies of cleavage-stage transfer reported this outcome. We
found no diIerence between the two groups (Peto OR 0.96, 95% CI
0.65 to 1.43; I2 = 40%; 6 studies, 1460 women). The miscarriage rate
per pregnancy was lower in DET group compared to SET following
cleavage stage transfer (Peto OR 1.65, 95% CI 1.06 to 2.56).
3.4.2 SET (×1) versus DET (×1) blastocyst stage
One study of blastocyst stage transfer reported this outcome and
there was no diIerence between the two groups (Peto OR 1.00,
95% CI 0.24 to 4.21; 1 study, 100 women).There was no diIerence
in miscarriage rate per pregnancy blastocysts stage subgroup (Peto
OR 1.38, 95% CI 0.32 to 6.06).
4. Double embryo transfer versus more than two embryos
transferred
Three studies tested other fresh cycle comparisons. Two were of
cleavage-stage transfer (Vauthier-Brouzes 1994; Heijnen 2006). The
day of transfer of the third study was not reported (Mostajeran
2006). Specific interventions were as follows (with the number of
cycles in brackets).
• DET (×1) versus triple embryo transfer (TET) (×1) (Heijnen 2006;
Mostajeran 2006)
• DET (×1) versus four embryo transfer (×1) (Vauthier-Brouzes
1994)
• DET (×2) versus TET (×2) (Heijnen 2006)
• DET (×3) versus TET (×3) (Heijnen 2006)
Primary outcomes
4.1 Live birth rate or cumulative live birth rate across single or
repeated IVF cycles
4.1.1 DET (×1) versus TET (×1)
We found no diIerence between the groups in the live birth rate (RR
0.48, 95% CI 0.14 to 1.68; 1 study, 45 women) (Heijnen 2006).
4.1.2 DET (×1) versus four embryo transfer (×1)
We found no diIerence between the groups in the live birth rate
(RR 0.53, 95% CI 0.27 to 1.05; 1 study, 56 women) (Vauthier-Brouzes
1994).
4.1.3 DET (×2) versus TET (×2)
We found no diIerence between the groups in the cumulative live
birth rate aFer two cycles of DET versus two cycles of TET (RR 0.84,
95% CI 0.37 to 1.92; 1 study, 45 women) (Heijnen 2006).
4.1.4 DET (×3) versus TET (×3)
We found no diIerence between the groups in the cumulative live
birth rate aFer three cycles of DET versus three cycles of TET (RR
0.86, 95% CI 0.43 to 1.71; 1 study, 45 women) (Heijnen 2006).
See Analysis 4.1.
Sensitivity analysis
There were no studies which were at low risk of bias for the
outcome. The overall findings did not materially change with the
use of a random-eIects model rather than a fixed-eIect model or
with use of odds ratio rather than risk ratio.
4.2 Multiple pregnancy rate
4.2.1 DET (×1) versus TET (×1)
There was lower multiple pregnancy rate in the DET group than in
the TET group (Peto OR 0.36, 95% CI 0.14 to 0.93; I2 = 0%; 2 studies,
343 women) (Heijnen 2006; Mostajeran 2006).
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4.2.2 DET (×1) versus four embryo transfer (×1)
We found no diIerence between the groups in the multiple




There were no studies which were at low risk of bias for the
outcome.
Secondary outcomes
4.3 Clinical pregnancy rate
4.3.1 DET (×1) versus TET (×1)
There was no diIerence between the groups in the clinical
pregnancy rate (RR 0.75, 95% CI 0.53 to 1.06; 2 studies, 343 women)
(Heijnen 2006; Mostajeran 2006).
4.3.2 DET (×1) versus four embryo transfer (×1)
We found no diIerence between the groups in the clinical




No studies reported this outcome.
5. Other fresh or frozen cycle comparisons
One study of cleavage-stage transfer compared DET versus TET
among 169 participants (Komori 2004). A total of 106 cycles of fresh
or frozen embryos were apparently administered in each group,
but study reporting was unclear and, moreover, outcomes were
reported per cycle rather than per woman. Attempts to contact
the authors were unsuccessful. Study findings were reported
descriptively below.
Primary outcomes
5.1 Cumulative live birth rate
5.1.1 DET versus TET, apparently using fresh or frozen embryos for
multiple cycles
We found no diIerence between the groups for this outcome using
'per cycle' data (30 versus 26 live births resulting from 106 cycles in
each group) (Komori 2004).
5.2 Multiple pregnancy rate
5.2.1 DET versus TET, apparently using fresh or frozen embryos for
multiple cycles
There was a lower incidence of multiple births per pregnancy in the
DET group (6/40 pregnancies versus 14/29 pregnancies) (Komori
2004).
Secondary outcomes
5.3 Clinical pregnancy rate
5.3.1 DET versus TET, apparently using fresh or frozen embryos for
multiple cycles
We found no diIerence between the groups for this outcome using
'per cycle' data (40 versus 29 pregnancies resulting from 106 cycles
in each group) (Komori 2004).
5.4 Miscarriage rate
This outcome was not reported.
D I S C U S S I O N
Summary of main results
The main finding of this updated systematic review is that low-
quality evidence indicates that live birth rate (LBR) may be reduced
by a strategy of elective single embryo transfer (SET) when
compared to double embryo transfer (DET) in a single fresh assisted
reproductive technology (ART) cycle. We observed the reduced LBR
following SET compared to DET in subgroups of women receiving
cleavage stage as well as blastocyst stage transfer. The risk of
multiple pregnancy is probably lower following SET compared
to DET and the quality of evidence was moderate (Summary of
findings 2). The clinical pregnancy rate per woman may be lower
in those who had SET in comparison with those who had DET in a
single fresh ART cycle. There may be little or no diIerence in the
miscarriage rate per women between those who had SET and those
who had DET.
AFer pooling of four studies of cleavage-stage transfer, low-quality
evidence suggests that the cumulative live birth rate aFer repeated
single embryo transfers (either SET followed by transfer of a single
frozen embryo in a natural or hormone-stimulated cycle, or two
fresh cycles of SET) may be no diIerent from that aFer a single
cycle of DET (Summary of findings 1). For a typical clinic with a 42%
chance of live birth following a single cycle of DET, the live birth rate
following repeated SET would be between 34% and 46%. Moderate-
quality evidence suggests that the multiple pregnancy rate aFer
repeated single embryo transfer is probably lower in comparison
with that aFer a single cycle of DET. This suggests that for a woman
with a 13% risk of multiple pregnancy following a single cycle of
DET, the risk following repeated SET would be between 0% and
3%. There may be little or no diIerence in clinical pregnancy and
miscarriage rates aFer consecutive SETs compared to the rates aFer
one cycle of DET.
Three studies of cleavage-stage transfer of fresh embryos compared
outcomes following DET versus three or four embryos. There
was no diIerence in live birth rates following a single ART cycle,
but the DET group was found to have lower multiple pregnancy
rates compared to the three embryo transfer (TET) group. The
cumulative live birth rate did not diIer between the two groups
following two and three ART cycles. The clinical pregnancy rate also
did not diIer between the two groups.
Most of the evidence currently available is from a cohort of younger
women (aged less than 35 years) with a good prognosis.
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Overall completeness and applicability of evidence
No studies compared repeated single versus repeated multiple
embryo transfer within the same ART cycle. This comparison
was planned in one study but the study was closed due to
poor enrolment, with only 23 participants (ECOSSE 2006). This
comparison would be a useful way to structure future trials in
order to determine the safety and eIectiveness of diIerent embryo
transfer policies, given that a number of embryos have been
produced. Policy in this context means the strategy for using up
the available embryos until success is achieved or the supply of
embryos is exhausted. A comparison of repeated multiple- versus
repeated single-embryo transfer would address the policy question
by determining ‘cumulative’ success rates.
The vast majority of participants in the studies included in the
current and previous versions of the review had a good prognosis
(aged under 36 years and with suIicient good-quality embryos).
Only two small studies focused on older women (Thurin 2005;
Heijnen 2006). One of the studies noted a potential for bias, as only a
small proportion of older women volunteered for the trial, probably
due to a preference for double embryos or twins, or both (Gardner
2004). Future studies should include older women and those with
previously failed IVF cycles or lack of good-quality embryos.
Per cycle, DET appears to be more expensive than SET (Tiitinen
2001; Gerris 2004; Thurin 2006; Chambers 2007; Fiddelers 2007).
The higher cost is mainly due to the increased rate of multiple births
and premature births in the DET group, and fewer pregnancies
in the SET group. Long-term costs related to multiple births and
prematurity in the DET group have not yet been adequately
assessed. A decision tree analysis indicated that the direct health
care costs of DET was higher than SET + 1FET across all age groups.
In women under 32 years, DET was less eIective (a lower live birth
rate) and more expensive than SET + 1FET. For women aged 32 and
over, DET was more eIective (a higher live birth rate) but still more
expensive than SET + 1FET (van Loendersloot 2017). Studies have
reported an increased risk of 'large for gestational age' (LGA) babies
following frozen cycles compared to fresh cycles, hence there is a
need to gather long-term safety data on children born following
frozen cycles (Maheshwari 2016; Maheshwari 2018). In order to
implement a policy of multiple single embryo transfers per woman,
providers require either an eIicient cryopreservation service or the
ability to provide multiple fresh IVF cycles. The former is likely to be
a safer and less invasive option for the women concerned.
Only three studies specifically addressed blastocyst transfer
(Gardner 2004; Prados 2015; Abuzeid 2017). There were only
two studies comparing DET with three embryo transfer (Heijnen
2006; Mostajeran 2006); and one study comparing DET versus
four embryo transfer (Vauthier-Brouzes 1994). It is unlikely that
such trials involving transfer of more than two embryos will be
conducted in the future due to unacceptably high risk of multiple
births.
Quality of the evidence
This update had five comparisons.
1. Repeated single embryo transfer versus repeated multiple
embryo transfer
2. Repeated single embryo transfer (mixed policies) versus
multiple embryo transfer in a single cycle
3. Single versus multiple embryo transfer in a single cycle
4. Double embryo transfer versus more than two embryos
transferred
5. Other fresh or frozen cycle comparisons
There were no studies reporting comparisons between repeated
SET versus repeated multiple embryo transfer. In the comparison
between repeated SET versus single cycle of DET, we reported on
cumulative live birth, multiple pregnancy, clinical pregnancy and
miscarriage rate for studies comparing repeated SET versus single
cycle of DET. The quality of evidence for primary outcomes was low
to moderate. We downgraded the level of evidence by one or two
levels due to unclear or high risk of selection bias due to inadequate
description of allocation concealment and high risk of performance
bias due to lack of blinding. We considered that awareness
of group allotment is likely to influence clinicians' behaviour
and performance for live birth and clinical pregnancy outcomes.
Substantial statistical heterogeneity was noted for miscarriage rate
but there was no obvious explanation. See Summary of findings 1.
For studies which reported single versus multiple embryo transfer
in a single cycle, we reported live birth, multiple pregnancy, clinical
pregnancy and miscarriage rate. The overall quality of evidence for
main outcomes was low to moderate. We categorised the majority
of studies at unclear risk of bias due to inadequate reporting of
allocation concealment and at high risk of performance bias due
to lack of blinding. We noted substantial statistical heterogeneity
for miscarriage rate but there was no obvious explanation. See
Summary of findings 2.
Three studies compared DET versus transfer of three or four
embryos. Studies were at unclear risk of bias for inadequate
reporting of allocation concealment methodology and at high risk
of performance bias due to lack of blinding.
Under the 'other fresh or frozen' comparison, we described the
results of one study which compared DET versus three embryo
transfer, apparently using fresh or frozen embryos for multiple
cycles. Only 'per cycle' data were available.
Potential biases in the review process
The search for the updated review was comprehensive, and
included a search for ongoing trials through clinical trial registries.
We contacted authors of three new studies asking for clarification
about their results and got a satisfactory reply from each one of
them.
One of the review authors was a primary investigator of one of the
included studies (ECOSSE 2006). Our comparison of one cycle of
fresh SET versus one cycle of DET includes data from studies for
which this was an interim analysis (Analysis 3.1). This may be a
potential source of bias. A post hoc sensitivity analysis excluding
these studies did not materially influence the live birth rate in this
analysis.
We are unaware of any other potential biases in the review process.
Agreements and disagreements with other studies or
reviews
Other studies and reviews are broadly in agreement with the
current review.
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A project commissioned by the UK National Institutes of
Health Research Health Technology Assessment Programme
used statistical modelling, analysis of registry and cohort data,
and exploration of consumer perspectives to explore options
for increasing SET and reducing the incidence of multiple
births (Roberts 2011). The analysis concluded that couples have
approximately one-third less chance of a live birth if they have one
fresh cycle of SET rather than DET, but that use of repeat cycles
using cryopreservation might compensate for the lost potential in
each individual transfer while reducing the likelihood of multiple
births. However, the authors recognised that a policy of repeat
SET (with use of cryopreserved eggs) would involve challenges
including appropriate patient selection, optimisation of freezing
techniques, and the emotional, financial and physical burden
associated with additional treatment cycles.
Earlier systematic reviews (Gelbaya 2010; McLernon 2010) and a
report from the American Society for Reproductive Medicine (ASRM
2012) have reached similar conclusions.
A large Dutch cohort study is currently in progress, which aims to
assess the long-term costs and health outcomes of ART singleton
and twin children and the long term cost-eIectiveness of SET
versus DET strategies. Outcomes were to be reported at 1-year, 5-
year and 18-year follow-up (van Heesch 2010). The investigators
have reported 5-year follow-up results and found significantly
higher hospital costs from birth up to the age of five years following
multiple birth compared to singleton birth (van Heesch 2015).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Although DET achieves higher live birth and clinical pregnancy
per fresh cycle, the evidence suggests that the diIerence in
eIectiveness may be substantially oIset when elective SET is
followed by a further transfer of a single embryo in fresh or frozen
cycle, while simultaneously reducing multiple pregnancies, at least
among women with a good prognosis.
The quality of evidence was low to moderate primarily due to
inadequate reporting of study methods and absence of masking
those delivering, as well as receiving the interventions.
Implications for research
More evidence is needed on policies for repeated embryo transfer,
including the most safe and eIective way to use available embryos
within a single ART cycle until success is achieved or the supply
of embryos is exhausted. As studies to date have been conducted
largely among women with a good prognosis undergoing ART,
future studies should include older women (above 36 years),
blastocyst stage transfers, subgroups categorised by cause of
infertility and those with previously failed ART cycles or without
good-quality embryos. Investigators should also consider blinding
of clinicians and embryologists to minimise the risk of performance
bias. The tasks of embryo transfer counselling and the embryo
transfer procedure may be performed by two diIerent individuals
to minimise bias. Longer-term cost-eIectiveness analyses are also
needed, which should take into account costs related to multiple
births and also costs of cryopreservation in the various strategies.
There is a need to gather more long-term safety data following
frozen cycles. While there are very few studies comparing double
embryo transfer versus three/four embryo transfer, it is unlikely
that such randomised trials involving transfer of more than two
embryos will be possible due to unacceptably high risk of multiple
births.
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Study characteristics
Methods Randomised controlled trial
Single centre
USA
Participants Inclusion criteria: women undergoing fresh assisted reproductive technology (ART); age < 35 years, day
3 follicle stimulating hormone (FSH) < 10 miu/ml; no history of poor response, no more than 1 previous
in vitro fertilisation (IVF) failure, no uterine cavity abnormalities and no contraindication to treatment
medications or procedures.
Exclusion criteria: patients with uterine abnormalities such as submucous fibroid, endometrial polyps,
uterine septum or significant uterine arcuate anomaly were not excluded if they were corrected hys-
teroscopically and post-procedure sono-infusion-hysterogram (SIH) was normal.
Interventions Intervention (n = 50): single fresh blastocyst transfer; if unsuccessful, a frozen double blastocyst trans-
fer was done.
Control (n = 50): fresh double blastocyst transfer was done.
However, since both arms received double blastocyst transfer, we did not take the data from second
cycle.
Outcomes Live birth rate, cumulative live birth rate, clinical pregnancy rate, multiple pregnancy rate, implantation
rate, miscarriage rate, ectopic rate
Notes The study was first published as a conference abstract. Subsequently, the study was published in peer
reviewed journal.
The authors were contacted for clarification. The authors replied to all study related queries.
The trial was registered (ISRCTN69937179).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Envelopes were prepared by research assistant who was not involved in re-
cruitment, consent, assignment or treatment. Group assignment was placed in
sequentially numbered, identical sealed envelopes. The subject group assign-
ment was blinded from the all study staI (nurse coordinator, nurses, embryol-






High risk Author reply: no blinding for clinician or embryologist.
We categorised the study to be at high risk for performance bias.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk The clinician or embryologist were not blinded. However, due to objective na-




Low risk Authors mention all the dropouts and exclusions. All the randomised women
are accounted for in the flow chart.
Abuzeid 2017 
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Low risk The trial was registered (ISRCTN69937179) and pre-stated outcomes were re-
ported in the manuscript
Other bias High risk Partially funded by Ferring Pharmaceuticals.
The authors provided trial registry number, the trial was retrospectively regis-
tered.
In the baseline characteristics, the proportion of excellent blastocysts trans-
ferred were significantly higher in SET group. This can potentially influence the
outcomes. Duration of infertility was mentioned.
The planned sample size was 200 (as per trial registry information), but just





Methods Multicentre randomised controlled trial
Participants Female age < 35 yrs if no previous ART pregnancy, < 40 if previous ART pregnancy. At least 4 good-quali-
ty embryos or at least 3 if previous ART pregnancy successful
27 women randomised
Interventions Cleavage-stage transfer:
SET (n = 13) versus DET (n = 14)
Eligibility into the trial was restricted to a single cycle of treatment. All subsequent cycles of treatment
were performed under conditions of routine care.
Outcomes Cumulative live birth, twin live birth, clinical ongoing pregnancy (fetal heartbeat), complications during
pregnancy, delivery and neonatal period, perinatal mortality and morbidity, use of neonatal intensive
care
Notes Unpublished trial. This study was stopped because its implementation immediately and substantial-
ly altered patients’ decision making, which more than tripled the rates of elective single embryo trans-
fer during the study period, and reduced participation rates (M Davies, University of Adelaide, personal
communication).
Funded by National Health and Medical Research Council Grant no: 158006) (M Davies, University of
Adelaide, personal communication)
Risk of bias






Low risk Pre-randomised envelopes were used and stored in the laboratory, opened in
numerical order
ASSETT 2003 
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Low risk Patients were not informed of the number of embryos transferred nor the
number of embryos suitable for freezing until immediately after their embryo
transfer, doctors were also not informed of the randomisation until after their
patients' embryo transfer, database manager and data analyser were also
blinded until completion of data analysis by using codes to represent the 2
treatment groups. The code was held by an independent third party
We categorised the study at low risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Patients were not informed of the number of embryos transferred nor the
number of embryos suitable for freezing until immediately after their embryo
transfer, doctors were also not informed of the randomisation until after their
patients' embryo transfer, database manager and data analyser were also
blinded until completion of data analysis by using codes to represent the 2
treatment groups. The code was held by an independent third party




Low risk No losses to follow-up
Selective reporting (re-
porting bias)
Low risk All outcomes described in the protocol were reported





Methods Randomised controlled trial
Single centre
Spain
Participants Included women were recipients between 18 and 50 years, undergoing first or second synchronised
fresh oocyte donation cycle with minimum of 5 embryos with at least 2 good-quality embryos on day 3
after oocyte retrieval
Exclusion:
Medical indication for single embryo transfer (Turner syndrome, uterine pathology/surgery, diabetes,
hypertension, cardiovascular disease, serious general disease) and severe male factor
Interventions Intervention (SET, n = 34): Elective single embryo transfer (since at least 2 good quality embryos on day
3 was entry criteria), They were transferred at cleavage stage
Control (DET, n = 31): Elective DET, Control had at least 2 good-quality embryos with 5 available em-
bryos on day 3 as entry eligibility. They were transferred at cleavage stage
Subsequent frozen cycle did not follow randomised numbers. They were DET in frozen cycle as per unit
policy. They were not included in the analysis
Outcomes Live birth rate, cumulative live birth, clinical pregnancy rate, implantation rates, multiple pregnancy
rate, miscarriage rate
Clua 2015 
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Notes The authors responded to all the study-related queries
The trial was terminated prematurely due to unacceptable high levels of multiple pregnancies in con-
trol arm
The trial was registered with clinical trial registry (NCT01228474)
Funding details were not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk “based on a computer generated simple randomization list”.
Allocation concealment
(selection bias)
Low risk “One or two embryos were transferred based on computer generated simple
randomization list with concealed allocation created by statistical and epi-
demiology unit”
Authors reply "We allocated the patients to a hidden random sequence





High risk Author reply: no blinding for clinician or embryologist
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Author reply: no blinding for clinician or embryologist
However, due to objective nature of outcomes, we categorised the study at




Low risk No attrition reported after randomisation in either group
Selective reporting (re-
porting bias)
Low risk The trial was registered (ClinicalTrials.gov Identifier: NCT01228474) and pre-
stated outcomes were reported in the manuscript
Other bias Unclear risk Baseline characteristics were comparable in both the groups
The trial was prematurely terminated. The trial was terminated (at 65) before
reaching the planned sample size (n = 160) due to high number of multiple





Methods Randomised controlled trial, computer-generated random sequence, n = 23 women analysed
Participants Inclusion criteria: all women receiving IVF or intracytoplasmic sperm injection (ICSI) treatment with
an optimal chance of achieving pregnancy, i.e. women aged less than 37 years, first or second cycle of
treatment, 4 or more good quality embryos at the time of embryo transfer
ECOSSE 2006 
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Exclusion criteria: women undergoing pre-implantation genetic diagnosis, or assisted hatching, or a
history of recurrent miscarriage
Interventions Cleavage-stage transfer:
SET fresh + multiple SET frozen (n = 11) versus DET fresh + multiple DET frozen (n = 12)
Both groups: if a pregnancy does not result in the fresh cycle, women will be encouraged to return for
replacement of frozen-thawed embryos in subsequent cycles over the next 12 months
Outcomes Cumulative live birth, twin live birth, clinical pregnancy (at least 1 gestational sac with heartbeat), bio-
chemical pregnancy (positive test), miscarriage, ectopic pregnancy preterm delivery, low birth weight,
congenital abnormality
Notes Unpublished trial. This study was stopped because of poor recruitment (planned for 700 women, en-
rolled only 23)
Funded by the Wellcome Trust (UK) (grant ref: 067469) and the Bertarelli Foundation (Switzerland)
Risk of bias












Low risk Double-blinded, couples and clinician or nurse who performed the embryo
transfer were blinded to the number of embryos transferred
We categorised the study at low risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Double-blinded, couples and clinician or nurse who performed the embryo
transfer were blinded to the number of embryos transferred
However, due to objective nature of outcomes, we categorised the study at




Low risk No losses to follow-up
Selective reporting (re-
porting bias)
Low risk All outcomes mentioned in the protocol were reported





Methods Randomised controlled trial. 48 women randomised
Gardner 2004 
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Participants Women aged up to 43 years, undergoing IVF and embryo transfer with their own oocytes. Day 3 FSH no
more than 10 mIU/ml, E2 under 80 pg/ml, hysteroscopically normal endometrial cavity, at least 10 folli-
cles over 12 mm in diameter on day of hCG administration
Interventions Blastocyst stage transfer:
Single versus double blastocyst transfer
Outcomes Ongoing pregnancy (defined as gestational sac with cardiac activity noted on ultrasound exam at least
4.5 weeks after embryo transfer), multiple gestation
Notes Supported in part by grants from Organon International and Vitrolife AB
Risk of bias











High risk Blinding status not stated
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Blinding status not stated
However, due to objective nature of outcomes, we categorised the study at




Unclear risk No dropouts mentioned, but results presented as percentages so it is unclear
whether all women were included in analysis
Selective reporting (re-
porting bias)
Unclear risk Live birth not reported
Other bias Unclear risk Baseline characteristics (indication for IVF, age, baseline ovarian reserve) simi-





Methods Randomised controlled trial. States external concealment for concealment of allocation. Good-quali-
ty embryos transferred, morphology of good-quality embryos defined. Protocols for ovarian stimula-
tion, oocyte retrieval, insemination and embryo transfer clearly described. Natural progesterone used
for luteal phase support. Semen was prepared using mini-percoll gradient prior to insemination. Me-
di-Cult medium used for embryo culture. Wallace embryo transfer catheter was used for transfer. Em-




Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Participants First IVF/ICSI cycle. Female age < 34 years. Average duration of infertility 3.5 years
Interventions 1 embryo transfer versus 2 embryo transfer
Outcomes Clinical pregnancy rate, live birth rate, multiple pregnancy rate per woman or couple and implantation
rates
Notes Method of randomisation not mentioned. Blinding not stated. Power calculation not reported. Inten-
tion-to-treat analysis not performed. Withdrawals and dropouts not mentioned clearly. Indication for
treatment not mentioned. Previous treatment not mentioned
Sponsored by the Foundation Marguerite-Marie Delacroix, dedicated to the prevention of cerebral pal-
sy, Belgium
Risk of bias











High risk Blinding status not stated
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Blinding status not stated
However, due to objective nature of outcomes, we categorised the study at




Low risk All randomised women included in analysis
Selective reporting (re-
porting bias)
Low risk Reports live birth and multiple pregnancy rates
Other bias Unclear risk Duration of infertility reported. Indication for treatment not mentioned. Previ-





Methods 2-centre randomised controlled trial. Randomisation performed before embryo quality was known
45 women randomised
Participants Patients on the waiting list for IVF/ICSI. Women > 38 years and had an indication for IVF/ICSI either for
the first time or after a previous IVF/ICSI childbirth
Heijnen 2006 
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Interventions Cleavage stage transfer (day 3 or 4): 2 embryo transfer in the first 3 cycles versus 3 embryo transfer in
the first 3 treatment cycles
Outcomes Cumulative live birth rate, live birth rate, multiple pregnancy rate
Notes Chi2 test and Mann–Whitney U test used for analysis. Randomisation was performed before information
on embryo quality was available. Power calculation not mentioned
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Remote: "Randomization was carried out using sealed envelopes opened by
the study coordinator on the phone"
Allocation concealment
(selection bias)
Low risk Remote: "Randomization was carried out using sealed envelopes opened by





High risk Blinding not mentioned.
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Blinding not mentioned
However, due to objective nature of outcomes, we categorised the study at




Low risk All 45 women analysed by intention to treat
Selective reporting (re-
porting bias)
Low risk Reports cumulative live birth rate, live birth rate, multiple pregnancy rate.






Participants Women attending IVF clinic: 169 analysed (212 cycles)
Interventions Cleavage-stage transfer (day 2): 2 versus 3 embryo transfer, number of cycles unclear
Outcomes Clinical pregnancy (gestational sac), ongoing pregnancy, live birth, multiple pregnancy
Notes 'Per cycle' data only
Risk of bias
Bias Authors' judgement Support for judgement
Komori 2004 
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Random sequence genera-
tion (selection bias)
Unclear risk Method not described; "patients were randomly divided into two groups"
Allocation concealment
(selection bias)





High risk Blinding not mentioned
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Blinding not mentioned
However, due to objective nature of outcomes, we categorised the study at




Unclear risk Dropouts and withdrawals not reported, 'per cycle' data only
Selective reporting (re-
porting bias)
Unclear risk Reports expected outcomes, but only as 'per cycle' data





Methods Randomised controlled trial
107 women randomised
Participants First IVF/ICSI cycle. Female age < 35 years, FSH < 10IU/L. At least 1 good-quality embryo should be avail-
able
Interventions Cleavage-stage transfer (day 3):
SET (2 cycles) versus DET transfer
In the second cycle protocol violations occurred in 4 patients (received 2 embryos)
Outcomes Clinical pregnancy rate, live birth rate, multiple pregnancy rates and miscarriage rates per woman/cou-
ple.
Cumulative pregnancy rates, Cumulative live birth rates, Cumulative multiple pregnancy rates and mis-
carriage rates for 1 plus 1 fresh embryo transfer
Notes Good quality embryos transferred, but morphologic characteristics not defined clearly. Embryo trans-
fer took place on day 3 after insemination. Patients and physicians not blinded to treatment. Power
calculation reported. Details of those lost to follow-up given. Duration of infertility and indication for
treatment provided. Protocols for IVF/ICSI described. Methods of statistical analysis mentioned Chi2
test and Student's t-test were used for analysis
Risk of bias
Bias Authors' judgement Support for judgement
Lukassen 2005 
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Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation
Allocation concealment
(selection bias)
Unclear risk "Allocation to the randomized group by an opaque, sealed envelope took
place just before embryo transfer by the laboratory personnel to maintain con-






High risk Patients and physicians not blinded to treatment
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Patients and physicians not blinded to treatment
However, due to objective nature of outcomes, we categorised the study at




Low risk All randomised women analysed
Selective reporting (re-
porting bias)
Low risk Reports cumulative live birth rate, live birth rate, multiple pregnancy rate





Methods Randomised controlled trial
Single centre
Spain
Participants Inclusion criteria: women undergoing IVF, < 38 years, BMI 19 to 29 kg/m2; FSH < 15 mIU/ml on day 3; first
or second cycle with previous attempt with positive pregnancy test.
Exclusion criteria: patients were excluded if infertility > 5 years; had previous surgery (fibroid, en-
dometriosis, hydrosalphinx); uterine malformations; repeated spontaneous abortions (2 or more).
Interventions Intervention (n = 84): 2 transfers; first fresh single embryo transfer followed by frozen SET if unsuccess-
ful. In some cases of OHSS with freeze all, single embryo transfer done in frozen cycle.
Control (n = 91): fresh double embryo transfer, on day 2 or 3
If freeze all for OHSS, then only 1 cycle of frozen transfer with 2 embryos.
Outcomes Live birth rate, cumulative live birth rate, clinical pregnancy rate, ongoing pregnancy rate, multiple
pregnancy rate, miscarriage rate.
Notes Authors replied to all the data related queries satisfactorily.
The trial was registered under clinical trial registry (NCT01909570).
López-Regalado 2014b 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk “computer generated randomization numbers...”
Allocation concealment
(selection bias)
High risk The allocation concealment was not described in the manuscript.
Author reply: randomisation was carried out through a list of random num-





High risk No clear mention of blinding in the manuscript.
Author reply:
Embryologist performed the interview for randomisation. Embryologist had
the information about group allotment. The study was double blind until the
day of transfer to clinicians, patients, nurses and embryologists.
Due to lack of blinding of clinician and embryologist on the day of embryo
transfer, we categorised the study at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk No clear mention of blinding in the manuscript.
However, due to objective nature of outcomes, we categorised the study at




Low risk The attrition was similar in both the arms. Intention-to-treat analysis was
done.
We categorised as low risk for attrition bias.
Selective reporting (re-
porting bias)
Low risk The trial was registered (ClinicalTrials.gov Identifier: NCT01909570).
All the prespecified outcomes were reported in the final manuscript.
Other bias Low risk Important baseline variables were similar in both the groups. Duration of infer-
tility mentioned.
Received institutional grant (Instituto Carlos III, code number: FIS09-1968).





Methods Multicentre randomised controlled trial
144 women randomised
Participants Fresh IVF/ICSI treatment who had/not had more than 1 previous failed treatment. Frozen embryo trans-
fers were analysed separately. At least 4 good-quality embryos should be available for inclusion in the
trial.
Interventions Cleavage-stage transfer: 1 embryo transfer (n = 74) versus 2 embryo transfer (n = 70).
Martikainen 2001 
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Good-quality embryos transferred. Morphology of good-quality embryos described clearly. Protocols
for IVF/ICSI clearly defined. Effectiveness of 1 versus 2 embryo transfer in frozen replacement cycles
analysed separately. All centres involved used various age limits for inclusion of women. Embryos cul-
tured in Medi-Cult medium. IVF-500 medium or Sydney IVF medium (Cook IVF) catheters were used
for embryo transfer. Embryo transfer performed 46 to 50 hours after oocyte recovery. Natural proges-
terone used for luteal phase support. Chi2 test and 2-tailed t-tests used for statistical analysis
Outcomes Reports clinical pregnancy rate, live birth rate, multiple pregnancy rates per woman/couple. Implanta-
tion and miscarriage rates
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random number table, balanced in sets of 10
Allocation concealment
(selection bias)





High risk Not stated
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Not stated
However, due to objective nature of outcomes, we categorised the study at




Low risk All women included in analysis
Selective reporting (re-
porting bias)
Low risk Reports cumulative live birth rate, live birth rate, multiple pregnancy rate






Participants ART candidates referred to university clinic, 298 analysed
Interventions 1 cycle of double embryo transfer (155 analysed) versus triple embryo transfer (143 analysed). Day of
transfer not reported
Outcomes Clinical pregnancy (fetal heart on ultrasound); multiple pregnancy
Notes  
Mostajeran 2006 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method not stated: "the subjects were randomly divided into two groups"
Allocation concealment
(selection bias)





High risk Blinding not mentioned
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Blinding not mentioned
However, due to objective nature of outcomes, we categorised the study at




High risk Women who did not follow the prescribed drug regimen or who had OHSS
were excluded (numbers not reported). 3 women with ectopic pregnancy also
excluded - not stated which group they were in
Selective reporting (re-
porting bias)
Unclear risk Live birth not reported





Methods Randomised open-label controlled trial, designed to show equivalence
Patients were informed on day 3 of embryo culture of the assigned group by their physician. Ran-
domised women were allowed to change group if they did not feel confident and expressed a desire to
modify the day or number of transferred embryos. Both ITT and per protocol analysis reported
Participants Inclusion criteria
Women requesting fertility treatment, aged under 38 years, and first trial of in vitro fertilisation or intra-
cytoplasmic sperm injection. At least 4 good-quality embryos on day 3 of embryo development
Exclusion criteria
Patients who underwent pre-implantation genetic diagnosis or oocyte donation treatments were ex-
cluded. Patients were also excluded if the sperm was not obtained from an ejaculate sample
199 women randomised
Interventions Day 3 of embryo culture:
Cleavage stage SET (n = 50)
Cleavage stage DET (n = 49)
Day 5 of embryo culture:
Prados 2015 
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Blastocyst stage SET (n = 50)
Blastocyst stage DET (n = 50)
The number of embryos transferred on subsequent thawed embryo cycles was determined indepen-
dently of the randomised group the patient belonged to. Protocols for IVF, embryo culture, transfer and
freezing reported in detail in study publication
Outcomes Multiple birth, live birth, patient acceptance
Notes In press December 2012
Study enrolment ceased before planned sample size (n = 412) due to change in embryo cryopreserva-
tion programme at IVI Seville.
Sponsored by the Instituto Valenciano de Infertilidad, Spain
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Use of web site Randomization.com to generate randomly permuted blocks of
8 subjects per block
Allocation concealment
(selection bias)
Low risk The randomisation was kept in a locked drawer in the administration office
where the clinical staI who enrolled participants had no access. The assigned





High risk Open label
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Open label
However, due to objective nature of outcomes, we categorised the study at




Low risk ITT outcomes reported for all women randomised
Selective reporting (re-
porting bias)
Low risk All expected outcomes reported
Other bias High risk Groups well-balanced at baseline
High proportion of participants changed groups (mostly from SET to DET):
Cleavage-stage SET = 30 (50 randomised)
Cleavage-stage DET = 71 (49 randomised)
Blastocyst-stage SET = 37 (50 randomised)
Blastocyst-stage DET = 57 (50 randomised)
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Study characteristics
Methods Multicentre randomised controlled trial
661 women randomised
Participants First or second IVF cycle who had at least 2 embryos of good quality available for transfer or freezing.
Female age < 36 years. Duration and cause for infertility mentioned
Interventions Transfer on day 2 (93%), day 3 (5%) (cleavage stage), or day 5 (2% to 3%) (blastocyst stage)
a. 1 embryo transfer (n = 330) versus 2 embryo transfer (n = 331)
b. 1 fresh plus 1 thawed embryo transfer cycle versus 2 embryo transfer (fresh)
Outcomes Clinical pregnancy rate, live birth rate, multiple pregnancy rates and miscarriage rates per woman/cou-
ple.
Cumulative pregnancy rates; cumulative live birth rates; cumulative multiple pregnancy rates and mis-
carriage rates for 1 embryo transfer plus 1 thawed embryo transfer cycle
Notes Power calculation performed. Good-quality embryos transferred, morphologic characteristics defined
clearly. Embryo transfer took place on day 2, 3 or 5 days after oocyte retrieval. Women lost to follow-up
mentioned. Fisher's non-parametric permutation test and Fisher's exact test used for statistical analy-
sis and 95% confidence intervals calculated.
8 women in each group (2.4%) had blastocyst transfer at day 5
Supported by a grant from Serono Nordic
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation at a ratio of 1:1
Allocation concealment
(selection bias)





Low risk Double-blind study
We categorised the study to be at low risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Double-blind study




Low risk All randomised women analysed
Selective reporting (re-
porting bias)
Low risk Cumulative live birth rate, live birth rate, multiple pregnancy rate
Other bias Unclear risk No mean duration of infertility given. 8 women in each group (2.4%) had blas-
tocyst transfer at day 5
Thurin 2004 
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Methods Multicentre randomised controlled trial. Computer-generated randomisation at a ratio of 1:1
27 women randomised
Participants Female age ≥ 36 years. First or second IVF/ICSI cycle. At least 2 good-quality embryos available
Interventions Transfer at cleavage stage (23/27; 85%) or blastocyst stage (4/27; 15%)
DET fresh versus SET fresh + SET frozen
Outcomes Reports live birth rate per woman, multiple live birth per woman
Notes Unpublished trial, pilot study, part of a thesis
Supported by a grant from Serono Nordic
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation at a ratio of 1:1
Allocation concealment
(selection bias)





Low risk Double-blind study
We categorised the study to be at low risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Double-blind study




Low risk Women lost to follow-up mentioned ITT performed
Selective reporting (re-
porting bias)
Low risk Reports cumulative live birth rate, live birth rate, multiple pregnancy rate





Methods Randomised controlled trial
308 women randomised
van Montfoort 2006 
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Participants First IVF cycle. Participants had to have at least 2 oocytes (2PN embryos)
Interventions Cleavage-stage transfer (day 2 or 3): 1 embryo versus 2 embryo transfer
Outcomes Reports clinical pregnancy rate, multiple pregnancy rate per woman/couple
Notes Randomisation performed immediately prior to embryo transfer, but method of randomisation not
stated. Patient population was stratified with respect to female age (< 38 and > 38 years), fertilisation
technique (IVF/ICSI). Power calculation performed. Number lost to follow-up mentioned. Duration and
cause for infertility mentioned. Analysis of variance (ANOVA) with Tukey's multiple test procedure and
Chi2 test were used for statistical analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method not described
Allocation concealment
(selection bias)
Unclear risk "by using a nontransparent box containing the sealed opaque envelopes, the






Low risk Double-blinded study
We categorised the study to be at low risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Double-blinded study




Low risk All randomised women included in analysis
Selective reporting (re-
porting bias)
Low risk Reports pregnancy rate, multiple pregnancy rate, miscarriage rate





Methods Randomised controlled trial
56 women included in analysis
Participants Fresh IVF/ICSI cycle. Frozen embryo transfers analysed separately. Age ≤ 35 years. Cleavage rate ≥ 70%
for IVF. Good-quality embryos transferred. Morphological characteristics of good-quality embryos de-
fined. Study and control groups were comparable in terms of age, number of hMG ampoules required
for ovarian stimulation, mean number of oocytes obtained and the number of embryos obtained. Indi-
cations for IVF was also comparable in both groups. Protocols for IVF/ICSI defined. HCG and natural
progesterone used for luteal phase support. IVF using donor sperm was also included and the number
Vauthier-Brouzes 1994 
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of patients who used donor sperm for IVF was also comparable in the 2 groups. Patients who had a sin-
gle, successful previous IVF attempt were also included
Interventions Cleavage stage transfer: 2 (n = 28) versus 4 (n = 28) embryo transfer
Outcomes Clinical pregnancy rate, live birth rate and multiple pregnancy rate per woman/couple
Notes Method of randomisation not mentioned. Blinding not stated. Allocation concealment not clear. Pow-
er calculation not reported. Intention-to-treat analysis not performed. Details of withdrawals, dropouts
not given. Duration of infertility and indication for treatment not provided. Methods of statistical analy-
sis not clearly mentioned. Embryo culture medium and catheter used for embryo transfer not de-
scribed. Day of embryo transfer also unclear
Risk of bias











High risk Not stated
We categorised the study to be at high risk for performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Not stated
However, due to objective nature of outcomes, we categorised the study at




Unclear risk Details of withdrawals, dropouts not given.
Selective reporting (re-
porting bias)
Low risk Reports live birth rate and multiple pregnancy rate per woman/couple
Other bias Unclear risk Day of embryo transfer also unclear
Vauthier-Brouzes 1994  (Continued)
ART - assisted reproductive technology; SET - single embryo transfer; DET - double embryo transfer; ICSI - intracytoplasmic sperm injection;
IVF - in vitro fertilisation; mIU/ml - milli international unit/ millilitre; RCT - randomised controlled trial; ITT - intention to treat; BMI - body
mass index; 2 PN - 2 pronuclei; OHSS - ovarian hyperstimulation syndrome; E2 - estradiol; kg/m2 - kilograms/ metre 2; pg/ml - picograms/
millilitre
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Bensdorp 2015 RCT comparing convention IVF and SET vs modified natural cycle IVF vs 3 cycles of IUI
Bowman 2004 Non-randomised study of double blastocyst transfer versus single blastocyst plus frozen transfers.
NB: same publication also includes Livingstone 2001.
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Study Reason for exclusion
Brabers 2016 Secondary analysis looking at decision-making process.
Eijkemans 2006 Review article on methodological considerations in decision making
Elgindy 2011 Compares cleavage versus blastocyst transfer. On average more embryos were transferred in the
cleavage-stage group but this was not prespecified policy.
Forman 2012 Compares quantitative chromosome-screened SET (pre implantation genetic screening) versus
morphology-based DET.
Forman 2013 Compares preimplantation genetic screening SET vs morphology based DET along with cost analy-
sis
Forman 2014 Compares obstetric outcomes of pregnancies following preimplantation genetic screening SET vs
morphology-based DET
Frattarelli 2003 Compares cleavage versus blastocyst transfer. On average more embryos were transferred in the
cleavage-stage group but this was not prespecified policy
Gardner 1998 Compares cleavage versus blastocyst transfer. On average more embryos were transferred in the
cleavage-stage group but this was not prespecified policy
Guerif 2011 Not randomised controlled trial
Harrild 2009 Individualised participant data (IPD) meta analysis
Hatırnaz 2016 In vitro maturation (IVM) cycles; retrospective study
Heijnen 2007 The ovarian stimulation regimes used for the 2 randomised groups (SET versus DET) were signifi-
cantly different
IRCT20141217020351N10 Compared sequential day 3 and day 5 transfer with single-day 5 embryo transfer
Lao 2017 Non randomised design
Levitas 2004 Compares cleavage versus blastocyst transfer. On average more embryos were transferred in the
cleavage-stage group but this was not prespecified policy
Livingstone 2001 No comparison of interest - compares double cleavage-stage embryo versus single blastocyst-stage
embryo. Mentioned in same paper as Bowman 2004
López-Regalado 2014a Retrospective cohort study
Motta 1998 A & B RCT comparing 3 to 5 cleavage-stage versus 1 to 3 blastocyst-stage embryos
Moustafa 2008 Quasi-randomised trial - days of week used
NCT03758833 Comparing morphology based screening (SET) vs pre implantation genetic screening SET
Pantos 2004 Compares cleavage versus blastocyst transfer. On average more embryos were transferred in the
cleavage-stage group but this was not prespecified policy
Rodriguez 2016 Pre-implantation genetic screening cost analysis study
Schoolcraft 2013 Review article
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Study Reason for exclusion
Staessen 1993 Not randomised controlled trial
Thurin 2009 Orginal trial was included which included randomised group evaluating SET vs DET. Current tri-
al looked at cumulative live birth following subsequent frozen transfer of 1 or 2 embryos (not ran-
domised in 1 or 2 embryos) on both arms
van Loendersloot 2017 Cost effectiveness study
van Montfoort 2005 Not randomised controlled trial
Yang 2016 Compared time lapse and preimplantation genetic screening versus only time lapse screening
Zhang 2015 Compared fresh conventional IVF DET vs minimal stimulation frozen SET cycles
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 2.   Repeated SET (mixed policies) versus multiple ET in a single cycle





Statistical method Effect size
2.1 Cumulative live birth 4 985 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.82, 1.10]
2.1.1 SET + 1 FET versus DET (x1)
(cleavage stage)
3 878 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.79, 1.09]
2.1.2 SET (x2) versus DET (x1) (cleav-
age stage)
1 107 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.70, 1.84]
2.2 Multiple pregnancy 4 985 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.13 [0.08, 0.21]
2.2.1 SET + 1 FET versus DET (x1)
(cleavage stage)
3 878 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.13 [0.08, 0.22]
2.2.2 SET (x2) versus DET (x1) (cleav-
age stage)
1 107 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.12 [0.03, 0.54]
2.3 Clinical pregnancy rate 3 943 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.87, 1.12]
2.3.1 SET + 1 FET versus DET (x1)
(cleavage stage)
2 836 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.84, 1.11]
2.3.2 SET (x2) versus DET (x1) (cleav-
age stage)
1 107 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.81, 1.71]
2.4 Miscarriage 2 282 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.14 [0.93, 4.95]
2.4.1 SET + 1 FET versus DET (x1)
(cleavage stage)
1 175 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.86 [0.85, 9.67]
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Statistical method Effect size
2.4.2 SET (x2) versus DET (x1) (cleav-
age stage)
1 107 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.65 [0.52, 5.23]
 
 
Analysis 2.1.   Comparison 2: Repeated SET (mixed policies) versus
multiple ET in a single cycle, Outcome 1: Cumulative live birth
Study or Subgroup






Heterogeneity: Chi² = 1.39, df = 2 (P = 0.50); I² = 0%
Test for overall effect: Z = 0.90 (P = 0.37)





Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 1.96, df = 3 (P = 0.58); I² = 0%
Test for overall effect: Z = 0.68 (P = 0.50)












































M-H, Fixed, 95% CI
1.08 [0.77 , 1.52]
0.90 [0.75 , 1.09]
0.63 [0.22 , 1.83]
0.93 [0.79 , 1.09]
1.14 [0.70 , 1.84]
1.14 [0.70 , 1.84]
0.95 [0.82 , 1.10]
Risk Ratio
M-H, Fixed, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours DET Favours SET
Footnotes
(1) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5
(2) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5)
 
 
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Analysis 2.2.   Comparison 2: Repeated SET (mixed policies) versus
multiple ET in a single cycle, Outcome 2: Multiple pregnancy
Study or Subgroup






Heterogeneity: Chi² = 0.01, df = 2 (P = 1.00); I² = 0%
Test for overall effect: Z = 7.54 (P < 0.00001)





Test for overall effect: Z = 2.75 (P = 0.006)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 0.02, df = 3 (P = 1.00); I² = 0%
Test for overall effect: Z = 8.03 (P < 0.00001)












































Peto, Fixed, 95% CI
0.13 [0.03 , 0.51]
0.13 [0.07 , 0.23]
0.15 [0.00 , 7.50]
0.13 [0.08 , 0.22]
0.12 [0.03 , 0.54]
0.12 [0.03 , 0.54]
0.13 [0.08 , 0.21]
Peto Odds Ratio
Peto, Fixed, 95% CI
0.01 0.1 1 10 100
Favours SET Favours DET
Footnotes
(1) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5
(2) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5)
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Analysis 2.3.   Comparison 2: Repeated SET (mixed policies) versus
multiple ET in a single cycle, Outcome 3: Clinical pregnancy rate
Study or Subgroup





Heterogeneity: Chi² = 2.85, df = 1 (P = 0.09); I² = 65%
Test for overall effect: Z = 0.48 (P = 0.63)





Test for overall effect: Z = 0.86 (P = 0.39)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 3.80, df = 2 (P = 0.15); I² = 47%
Test for overall effect: Z = 0.16 (P = 0.87)







































M-H, Fixed, 95% CI
1.22 [0.90 , 1.64]
0.91 [0.78 , 1.06]
0.97 [0.84 , 1.11]
1.18 [0.81 , 1.71]
1.18 [0.81 , 1.71]
0.99 [0.87 , 1.12]
Risk Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Favours DET Favours SET
Footnotes
(1) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5
 
 
Analysis 2.4.   Comparison 2: Repeated SET (mixed policies)
versus multiple ET in a single cycle, Outcome 4: Miscarriage
Study or Subgroup





Test for overall effect: Z = 1.69 (P = 0.09)





Test for overall effect: Z = 0.85 (P = 0.40)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 0.41, df = 1 (P = 0.52); I² = 0%
Test for overall effect: Z = 1.78 (P = 0.08)


































Peto, Fixed, 95% CI
2.86 [0.85 , 9.67]
2.86 [0.85 , 9.67]
1.65 [0.52 , 5.23]
1.65 [0.52 , 5.23]
2.14 [0.93 , 4.95]
Peto Odds Ratio
Peto, Fixed, 95% CI
0.01 0.1 1 10 100
Favours SET Favours DET
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Comparison 3.   Single versus multiple embryo transfer (in a single cycle)





Statistical method Effect size
3.1 Live birth 12 1904 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.59, 0.75]
3.1.1 SET (x1) versus DET (x1) (cleav-
age stage)
11 1704 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.59, 0.76]
3.1.2 SET (x1) versus DET (x1) (blasto-
cyst stage)
2 200 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.51, 0.84]
3.2 Multiple pregnancy 13 1952 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.16 [0.12, 0.22]
3.2.1 SET (x1) versus DET (x1) (cleav-
age stage)
11 1704 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.16 [0.11, 0.22]
3.2.2 SET (x1) versus DET (x1) (blasto-
cyst stage)
3 248 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.18 [0.09, 0.36]
3.3 Clinical pregnancy rate 10 1860 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.64, 0.77]
3.3.1 SET (x1) versus DET (x1) (cleav-
age stage)
8 1612 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.62, 0.78]
3.3.2 SET (x1) versus DET (x1) (blasto-
cyst stage)
3 248 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.62, 0.88]
3.4 Miscarriage 7 1560 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.96 [0.66, 1.42]
3.4.1 SET (x1) versus DET (x1) (cleav-
age stage)
6 1460 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.96 [0.65, 1.43]
3.4.2 SET (x1) versus DET (x1) (blasto-
cyst stage)
1 100 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.00 [0.24, 4.21]
 
 
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Analysis 3.1.   Comparison 3: Single versus multiple embryo transfer (in a single cycle), Outcome 1: Live birth
Study or Subgroup














Heterogeneity: Chi² = 6.43, df = 10 (P = 0.78); I² = 0%
Test for overall effect: Z = 6.13 (P < 0.00001)





Heterogeneity: Chi² = 0.16, df = 1 (P = 0.69); I² = 0%
Test for overall effect: Z = 3.31 (P = 0.0009)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 6.64, df = 12 (P = 0.88); I² = 0%
Test for overall effect: Z = 6.89 (P < 0.00001)

























































































M-H, Fixed, 95% CI
0.65 [0.19 , 2.18]
0.80 [0.49 , 1.32]
1.09 [0.50 , 2.38]
0.49 [0.27 , 0.88]
0.72 [0.41 , 1.29]
0.86 [0.59 , 1.25]
0.74 [0.47 , 1.17]
0.68 [0.48 , 0.98]
0.64 [0.52 , 0.80]
0.63 [0.22 , 1.83]
0.54 [0.38 , 0.78]
0.67 [0.59 , 0.76]
0.69 [0.49 , 0.96]
0.62 [0.42 , 0.90]
0.65 [0.51 , 0.84]
0.67 [0.59 , 0.75]
Risk Ratio
M-H, Fixed, 95% CI
0.5 0.7 1 1.5 2
Favours DET Favours SET
Footnotes
(1) Study included only oocyte donation cycles
(2) Interim analysis from (planned) multi-cycle study.
(3) Interim analysis from multi-cycle study.
(4) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5. Interim analysis from multi-cycle study.
(5) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5). Interim analysis from multi-cycle study.
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Analysis 3.2.   Comparison 3: Single versus multiple embryo
transfer (in a single cycle), Outcome 2: Multiple pregnancy
Study or Subgroup














Heterogeneity: Chi² = 6.27, df = 10 (P = 0.79); I² = 0%
Test for overall effect: Z = 10.04 (P < 0.00001)






Heterogeneity: Chi² = 4.75, df = 2 (P = 0.09); I² = 58%
Test for overall effect: Z = 4.72 (P < 0.00001)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 11.11, df = 13 (P = 0.60); I² = 0%
Test for overall effect: Z = 11.09 (P < 0.00001)






























































































Peto, Fixed, 95% CI
0.15 [0.00 , 7.35]
0.09 [0.02 , 0.37]
0.15 [0.00 , 7.44]
0.21 [0.04 , 1.00]
0.12 [0.03 , 0.54]
0.13 [0.03 , 0.51]
0.15 [0.05 , 0.50]
0.46 [0.17 , 1.23]
0.13 [0.07 , 0.23]
0.15 [0.00 , 7.50]
0.12 [0.04 , 0.38]
0.16 [0.11 , 0.22]
0.10 [0.03 , 0.31]
0.10 [0.02 , 0.42]
0.55 [0.16 , 1.90]
0.18 [0.09 , 0.36]
0.16 [0.12 , 0.22]
Peto Odds Ratio
Peto, Fixed, 95% CI
0.01 0.1 1 10 100
Favours SET Favours DET
Footnotes
(1) Study included only oocyte donation cycles
(2) Interim analysis from (planned) multi-cycle study.
(3) Interim analysis from multi-cycle study.
(4) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5.Interim analysis from multi-cycle study.
(5) Includes three women in the DET group and one in the SET group who had blastocyst transfer (day 5).Interim analysis from multi-cycle study.
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Analysis 3.3.   Comparison 3: Single versus multiple embryo
transfer (in a single cycle), Outcome 3: Clinical pregnancy rate
Study or Subgroup











Heterogeneity: Chi² = 8.61, df = 7 (P = 0.28); I² = 19%
Test for overall effect: Z = 6.31 (P < 0.00001)






Heterogeneity: Chi² = 0.31, df = 2 (P = 0.86); I² = 0%
Test for overall effect: Z = 3.41 (P = 0.0006)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 9.16, df = 10 (P = 0.52); I² = 0%
Test for overall effect: Z = 7.11 (P < 0.00001)















































































M-H, Fixed, 95% CI
0.79 [0.50 , 1.24]
0.69 [0.46 , 1.04]
0.79 [0.50 , 1.23]
0.98 [0.70 , 1.36]
0.69 [0.46 , 1.04]
0.81 [0.60 , 1.08]
0.64 [0.53 , 0.77]
0.53 [0.37 , 0.76]
0.69 [0.62 , 0.78]
0.75 [0.58 , 0.98]
0.80 [0.54 , 1.19]
0.70 [0.53 , 0.93]
0.74 [0.62 , 0.88]
0.70 [0.64 , 0.77]
Risk Ratio
M-H, Fixed, 95% CI
0.7 0.85 1 1.2 1.5
Favours DET Favours SET
Footnotes
(1) Study included only oocyte donation cycles
(2) Interim analysis from multi-cycle study.
(3) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5.Interim analysis from multi-cycle study.
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Analysis 3.4.   Comparison 3: Single versus multiple embryo transfer (in a single cycle), Outcome 4: Miscarriage
Study or Subgroup









Heterogeneity: Chi² = 8.27, df = 5 (P = 0.14); I² = 40%
Test for overall effect: Z = 0.19 (P = 0.85)





Test for overall effect: Z = 0.00 (P = 1.00)
Total (95% CI)
Total events:
Heterogeneity: Chi² = 8.27, df = 6 (P = 0.22); I² = 27%
Test for overall effect: Z = 0.18 (P = 0.85)



























































Peto, Fixed, 95% CI
0.46 [0.05 , 4.56]
1.20 [0.35 , 4.15]
2.53 [0.71 , 9.06]
0.34 [0.05 , 2.47]
0.61 [0.34 , 1.10]
1.70 [0.79 , 3.65]
0.96 [0.65 , 1.43]
1.00 [0.24 , 4.21]
1.00 [0.24 , 4.21]
0.96 [0.66 , 1.42]
Peto Odds Ratio
Peto, Fixed, 95% CI
0.01 0.1 1 10 100
Favours SET Favours DET
Footnotes
(1) Study included only oocyte donation cycles
(2) Includes 8 women in each group (2.4%) who had blastocyst transfer at day 5. Interim analysis from multi-cycle study.
 
 
Comparison 4.   Double embryo transfer versus more than two embryos transferred





Statistical method Effect size
4.1 Live or cumulative live birth 2   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1.1 DET (x1) versus TET (x1) 1 45 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.14, 1.68]
4.1.2 DET (x1) versus four embryo transfer
(x1)
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.27, 1.05]
4.1.3 DET (x2) versus TET (x2) 1 45 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.37, 1.92]
4.1.4 DET (x3) versus TET (x3) 1 45 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.43, 1.71]
4.2 Multiple pregnancy 3   Peto Odds Ratio (Peto, Fixed, 95%
CI)
Subtotals only
4.2.1 DET versus TET 2 343 Peto Odds Ratio (Peto, Fixed, 95%
CI)
0.36 [0.14, 0.93]
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Statistical method Effect size
4.2.2 DET versus four embryo transfer 1 56 Peto Odds Ratio (Peto, Fixed, 95%
CI)
0.46 [0.11, 1.88]
4.3 Clinical pregnancy 3   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.3.1 DET (x1) versus TET (x1) 2 343 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.53, 1.06]
4.3.2 DET (x1) versus four embryo transfer
(x1)
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.47, 1.26]
 
 
Analysis 4.1.   Comparison 4: Double embryo transfer versus more than
two embryos transferred, Outcome 1: Live or cumulative live birth
Study or Subgroup





Test for overall effect: Z = 1.15 (P = 0.25)





Test for overall effect: Z = 1.81 (P = 0.07)





Test for overall effect: Z = 0.42 (P = 0.67)






















































M-H, Fixed, 95% CI
0.48 [0.14 , 1.68]
0.48 [0.14 , 1.68]
0.53 [0.27 , 1.05]
0.53 [0.27 , 1.05]
0.84 [0.37 , 1.92]
0.84 [0.37 , 1.92]
0.86 [0.43 , 1.71]
0.86 [0.43 , 1.71]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours TET or FET Favours DET
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Analysis 4.2.   Comparison 4: Double embryo transfer versus more
than two embryos transferred, Outcome 2: Multiple pregnancy
Study or Subgroup





Heterogeneity: Chi² = 0.64, df = 1 (P = 0.42); I² = 0%
Test for overall effect: Z = 2.10 (P = 0.04)







































Peto, Fixed, 95% CI
0.12 [0.01 , 2.04]
0.42 [0.15 , 1.14]
0.36 [0.14 , 0.93]
0.46 [0.11 , 1.88]
0.46 [0.11 , 1.88]
Peto Odds Ratio
Peto, Fixed, 95% CI
0.01 0.1 1 10 100
Favours DET Favours TET or FET
 
 
Analysis 4.3.   Comparison 4: Double embryo transfer versus more
than two embryos transferred, Outcome 3: Clinical pregnancy
Study or Subgroup





Heterogeneity: Chi² = 0.83, df = 1 (P = 0.36); I² = 0%
Test for overall effect: Z = 1.63 (P = 0.10)





Test for overall effect: Z = 1.06 (P = 0.29)


































M-H, Fixed, 95% CI
1.12 [0.44 , 2.80]
0.70 [0.48 , 1.02]
0.75 [0.53 , 1.06]
0.76 [0.47 , 1.26]
0.76 [0.47 , 1.26]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours TET Favours DET
 
 
A D D I T I O N A L   T A B L E S
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Previous failed cycle Frozen cycles Prim/Sec in-
fertility
FSH Quality of embryo
Prados 2015 Under 38 years (mean
age 33)
Mean 2.6 to 3.2
years
First IVF/ICSI cycle. Frozen cycles in-
cluded
Not stated Not stated Good
Gerris 1999 less than 34 years Average duration
of infertility 3.5
years.
First IVF/ICSI cycle. Not included Unclear Not men-
tioned
Good
Heijnen 2006 38 to 45 years (mean age
41)
Average duration
of infertility in DET
group was 3.7(±
2.5) and in TET
group was 3.2(±
2.4) years
First cycle and previous
successful cycle
Not included Yes Not men-
tioned
Good
Komori 2004 Not stated Not stated Not stated Not stated Not stated Not stated Good
Lukassen
2005
< 35 years (mean age 30
to 31)
Not stated First IVF/ICSI cycle or af-
ter previous successful
cycle .
Not included Yes FSH < 10IU/L. Good
Martikainen
2001
various, no age criteria,
ranged between 22 to 40
years (mean age 31)
Not stated women who had / not











Not stated Not stated Not stated Not stated Not stated Not stated Good











































































































































































Various ages, no criteria
(mean age 33)
SET- 3.3 ± 1.8, DET-
3.3 ± 2.1 years


























At least 4 good-
quality
embryos or at least

















Abuzeid 2017 < 35 years SET - 2.6 ± 1.6 years
DET - 3.2 ± 2.4 years






Yes Mentioned At least 2 good-
quality blastocysts
were available,
Clua 2015 oocyte donor recipients
aged 18-50 years











Minimum of 5 em-
bryos with at least
2 good-quality em-




< 38 years SET - 3.1 ± 1.1
DET - 3.1 ± 1.0
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A P P E N D I C E S
Appendix 1. Cochrane Gynaecology and Fertility specialised register search strategy
PROCITE platform
Searched 16 March 2020
Keywords CONTAINS "Number of blastocysts" or "number of blastocysts transferred" or "number of embryos" or "number of embryos
transferred" or "triple embryos transfer" or "single blastocyst transfer" or "single embryo transfer" or "single vs multiple" or "single vs
multiple transfer" or "double embryo transfer" or "triple embryos transfer" or "three embryos transfer" or "SET" or "two embryos" or Title
CONTAINS "Number of blastocysts" or "number of blastocysts transferred" or "number of embryos" or "number of embryos transferred" or
"triple embryos transfer" or "single blastocyst transfer" or "single embryo transfer" or "single vs multiple" or "single vs multiple transfer"
or "double embryo transfer" or "triple embryos transfer" or "three embryos transfer" or "SET" or "two embryos"
AND
Keywords CONTAINS "ivf" or "ICSI" or "subfertility" or Title CONTAINS "ivf" or "ICSI" or "subfertility"
(1250 records)
Appendix 2. CENTRAL Register of Studies Online (CRSO) search strategy
Web platform
Searched 16 March 2020
#1 MESH DESCRIPTOR Embryo Transfer EXPLODE ALL TREES 1072
#2 (Embryo* adj5 Transfer*):TI,AB,KY 3969
#3 (blastocyst* adj5 Transfer*):TI,AB,KY 472
#4 #1 OR #2 OR #3 4087
#5 (one adj2 embryo*):TI,AB,KY 136
#6 (single adj2 embryo*):TI,AB,KY 295
#7 (single adj2 blastocyst*):TI,AB,KY 119
#8 (one adj2 blastocyst*):TI,AB,KY 32
#9 (two adj2 embryo*):TI,AB,KY 238
#10 (double adj2 embryo*):TI,AB,KY 224
#11 (double adj2 blastocyst*):TI,AB,KY 2
#12 (two adj2 blastocyst*):TI,AB,KY 46
#13 (three adj2 embryo*):TI,AB,KY 109
#14 (triple adj2 embryo*):TI,AB,KY 3
#15 (triple adj2 blastocyst*):TI,AB,KY 0
#16 (three adj2 blastocyst*):TI,AB,KY 3
#17 (multiple adj2 blastocyst*):TI,AB,KY 3
#18 (multiple adj2 embryo*):TI,AB,KY 41
#19 (SET or DET or TET):TI,AB,KY 26970
#20 (SBT or DBT or TBT):TI,AB,KY 756
#21 (four adj2 embryo*):TI,AB,KY 39
#22 (four adj2 blastocyst*):TI,AB,KY 1
#23 #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 28576
#24 #4 AND #23 882
Appendix 3. MEDLINE search strategy
OVID platform
Searched from 1946 to 16 March 2020
1 Embryo Transfer/ (15557)
2 (Embryo$ adj5 Transfer$).tw. (18859)
3 (blastocyst$ adj5 transfer$).tw. (2479)
4 exp embryo, mammalian/ or exp blastocyst/ (93114)
5 or/1-4 (112678)
6 (two adj2 embryo$).tw. (3566)
7 (double adj2 embryo$).tw. (643)
8 DET.tw. (1117)
9 (three adj2 embryo$).tw. (1944)
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10 (triple adj2 embryo$).tw. (45)
11 TET$.tw. (450651)
12 (two adj2 blastocyst$).tw. (273)
13 (double adj2 blastocyst$).tw. (34)
14 (three adj2 blastocyst$).tw. (122)
15 (triple adj2 blastocyst$).tw. (4)
16 DBT.tw. (2494)
17 TBT.tw. (1746)
18 (one adj2 embryo$).tw. (2295)
19 (single adj2 embryo$).tw. (2109)
20 SET.tw. (510321)
21 (one adj2 blastocyst$).tw. (236)
22 (single adj2 blastocyst$).tw. (388)
23 SBT.tw. (2058)
24 (four adj2 embryo$).tw. (962)
25 (four adj2 blastocyst$).tw. (80)
26 FET.tw. (3167)
27 FZET.tw. (0)
28 (multiple$ adj2 embryo$).tw. (727)
29 (multiple$ adj2 blastocyst$).tw. (22)
30 (quadruple adj2 embryo$).tw. (5)
31 (quadruple adj2 blastocyst$).tw. (1)
32 or/6-31 (972810)
33 5 and 32 (9191)
34 randomized controlled trial.pt. (501858)
35 controlled clinical trial.pt. (93575)
36 randomized.ab. (473201)
37 placebo.tw. (211687)
38 clinical trials as topic.sh. (190393)
39 randomly.ab. (329293)
40 trial.ti. (215152)
41 (crossover or cross-over or cross over).tw. (83825)
42 or/34-41 (1305981)
43 exp animals/ not humans.sh. (4678649)
44 42 not 43 (1200138)
45 33 and 44 (479)
Appendix 4. Embase search strategy
OVID platform
Searched from 1980 to 16 March 2020
1 Embryo Transfer/ (29832)
2 (Embryo$ adj5 Transfer$).tw. (29099)
3 (blastocyst$ adj5 transfer$).tw. (4752)
4 exp embryo, mammalian/ or exp blastocyst/ (28866)
5 or/1-4 (59994)
6 (two adj2 embryo$).tw. (4269)
7 (double adj2 embryo$).tw. (999)
8 DET.tw. (1537)
9 (three adj2 embryo$).tw. (2348)
10 (triple adj2 embryo$).tw. (65)
11 TET$.tw. (473237)
12 (two adj2 blastocyst$).tw. (406)
13 (double adj2 blastocyst$).tw. (102)
14 (three adj2 blastocyst$).tw. (161)
15 (triple adj2 blastocyst$).tw. (5)
16 DBT.tw. (3402)
17 TBT.tw. (2248)
18 (one adj2 embryo$).tw. (3129)
19 (single adj2 embryo$).tw. (3734)
20 SET.tw. (649215)
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21 (one adj2 blastocyst$).tw. (410)
22 (single adj2 blastocyst$).tw. (896)
23 SBT.tw. (3782)
24 (four adj2 embryo$).tw. (1078)
25 (four adj2 blastocyst$).tw. (105)
26 FET.tw. (4510)
27 FZET.tw. (0)
28 (multiple$ adj2 embryo$).tw. (1063)
29 (multiple$ adj2 blastocyst$).tw. (46)
30 (quadruple adj2 embryo$).tw. (7)
31 (quadruple adj2 blastocyst$).tw. (1)
32 or/6-31 (1140425)
33 5 and 32 (11074)
34 Clinical trial/ (956829)
35 Randomized controlled trials/ (175321)
36 Random Allocation/ (82227)
37 Single-Blind Method/ (36164)
38 Double-Blind Method/ (142855)
39 Cross-Over Studies/ (50639)
40 Placebos/ (277114)
41 Randomi?ed controlled trial$.tw. (222841)
42 RCT.tw. (36001)
43 Random allocation.tw. (1981)
44 Randomly allocated.tw. (34385)
45 Allocated randomly.tw. (2509)
46 (allocated adj2 random).tw. (810)
47 Single blind$.tw. (24170)
48 Double blind$.tw. (199664)
49 ((treble or triple) adj blind$).tw. (1107)
50 Placebo$.tw. (298020)
51 Prospective Studies/ (480306)
52 or/34-51 (2020914)
53 Case study/ (67370)
54 Case report.tw. (394310)
55 Abstract report/ or letter/ (1084934)
56 or/53-55 (1536415)
57 52 not 56 (1964442)
58 animal/ (1323785)
59 human/ (20095580)
60 58 not 59 (958622)
61 57 not 60 (1932644)
62 33 and 61 (1211)
Appendix 5. PsycINFO search strategy
OVID platform
Searched from 1806 to 16 March 2020
1 exp Infertility/ or exp Reproductive Technology/ (3474)
2 (Embryo$ adj5 Transfer$).tw. (175)
3 (blastocyst$ adj5 transfer$).tw. (6)
4 or/1-3 (3551)
5 (two adj2 embryo$).tw. (41)
6 (double adj2 embryo$).tw. (16)
7 DET.tw. (166)
8 (three adj2 embryo$).tw. (15)
9 (triple adj2 embryo$).tw. (0)
10 (two adj2 blastocyst$).tw. (0)
11 (three adj2 blastocyst$).tw. (0)
12 (one adj2 embryo$).tw. (34)
13 (single adj2 embryo$).tw. (30)
14 (four adj2 embryo$).tw. (9)
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
15 or/5-14 (300)
16 4 and 15 (24)
Appendix 6. CINAHL search strategy
EBSCO platform
Searched from 1961 to 16 March 2020
S47 S23 AND S46 219
S46 S45 NOT S44 634,392
S45 S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 663,188
S44 S42 NOT S43 168,310
S43 MH (human) 2,045,086
S42 S39 OR S40 OR S41 191,371
S41 TI (animal model*) 2,899
S40 MH (animal studies) 111,330
S39 MH animals+ 87,856
S38 AB (cluster W3 RCT) 327
S37 MH (crossover design) OR MH (comparative studies) 259,647
S36 AB (control W5 group) 100,230
S35 PT (randomized controlled trial) 87,859
S34 MH (placebos) 11,654
S33 MH (sample size) AND AB (assigned OR allocated OR control) 3,787
S32 TI (trial) 100,205
S31 AB (random*) 284,114
S30 TI (randomised OR randomized) 98,224
S29 MH cluster sample 4,074
S28 MH pretest-posttest design 39,788
S27 MH random assignment 57,798
S26 MH single-blind studies 13,185
S25 MH double-blind studies 43,656
S24 MH randomized controlled trials 91,194
S23 S4 AND S22 873
S22 S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 3,454
S21 TX TBT or TX DBT 796
S20 TX TET or TX DET 1,244
S19 TX (single N2 embryo*) 453
S18 TX (single N2 blastocyst*) 114
S17 TX (one N2 blastocyst*) 39
S16 TX (double N2 blastocyst*) 4
S15 TX (two N2 blastocyst*) 29
S14 TX (three N2 blastocyst*) 22
S13 TX (four N2 blastocyst*) 13
S12 TX (multiple N2 blastocyst*) 3
S11 TX (multiple N2 embryo*) 170
S10 TX (four N2 embryo*) 102
S9 TX (triple N2 embryo*) 5
S8 TX (three N2 embryo*) 247
S7 TX (one N2 embryo*) 270
S6 TX (double N2 embryo*) 98
S5 TX (two N2 embryo*) 329
S4 S1 OR S2 OR S3 3,283
S3 TX (blastocyst* N5 Transfer*) 401
S2 TX (Embryo* N5 Transfer*) 3,191
S1 (MM "Embryo Transfer") 1,122
W H A T ' S   N E W
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Date Event Description
18 May 2020 New citation required but conclusions
have not changed
The addition of 3 new trials added more strength to existing data
but overall conclusions did not change.
18 May 2020 New search has been performed The review was updated in March 2020. MSK lead a new team
of authors including MM and RK. Previous author SB provided
important inputs to the current update. Three new trials were
added in this review: López-Regalado 2014b; Clua 2015; Abuzeid
2017. We have presented the results and conclusions as per lat-
est Cochrane editorial guidelines.Risk of bias for older studies
changed. We used risk ratio instead of odds ratio for dichoto-
mous outcomes and Peto odds ratio for outcomes that were as-
sociated with low event rates.
 
H I S T O R Y
Protocol first published: Issue 1, 2002
Review first published: Issue 4, 2004
 
Date Event Description
1 June 2014 Amended Analyses of single embryo transfer versus double embryo trans-
fer changed so that single embryo transfer is now regarded as
the intervention and double embryo transfer as the control, in
order to make the nature of the comparison more clinically ap-
propriate. Text and summary of findings table edited according-
ly. Errors in display of some of tables of analysis corrected in or-
der to show OR consistently. Assessed as up to date and Search
dates corrected.
25 July 2013 New search has been performed The search was updated to July 2013
Comparisons of different numbers of blastocysts were added
(previously only cleavage-stage embryo comparisons were in-
cluded)
Seven extra completed studies were included (ASSETT 2003,
Gardner 2004, Komori 2004, Thurin 2005, ECOSSE 2006, Mostajer-
an 2006, Manuel-Fernandez 2012)
The structure of the table of comparisons was reformatted
25 July 2013 New citation required but conclusions
have not changed
No change to conclusions
29 August 2011 New search has been performed Review updated Aug 2011.
Objective- wording has been changed
Three unplished trials (ASSETT 2003; Thurin 2005; ECOSSE 2006)
have been added to comparison 1
Comparison 2 has been changed to DET vs SET (2 or more cy-
cles), the sub comparisons now include DET vs 2 fresh SET, DET
vs SET plus 1FZET, DET plus FZET vs SET +FZET and has addi-
tional data from 2 unpublished trials. The original Comparison 3
from previous review has therefore been deleted and included in
Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection (Review)









Cochrane Database of Systematic Reviews
Date Event Description
comparison 2. Comparison 5 from previous review has also been
deleted and added to comparison 4 of the updated review. This
updated review will have 3 comparisons.
8 May 2008 New search has been performed A new literature search was performed on 30/03/2008 by two re-
viewers independently (ZP, OO).
Five new trials were identified using the Cochrane search strat-
egy for identifying new trials.Search redesigned and run March
2008. Three new trials were added to the review.
One trial (Thurin 2004) included blastocyst transfers. Blastocyst
transfers were excluded from the data analysed.
Two trials (Thurin2004 and van Montfoort 2006) compared one
embryo transfer versus two embryo transfer. One trial (Thurin
2004) also compared one embryo transfer followed by a frozen-
thawed single embryo transfer versus two embryo transfer.
Livebirth rates from Van Montfoort 2006 study was derived from
another publication from the same study and appears as van
Montfoort* 2006 in the review and references.
A single trial (Heijnen 2006) compared two embryo transfer ver-
sus three embryo transfer. The trial also determined the cumula-
tive effect of multiple transfers of two and three embryos.
A trial included in the original review (Lukassen 2002) that com-
pared single embryo transfer versus double embryo was updat-
ed and published in 2005. This review has also been updated
with this trial.
Two trials (Komori 2004; Mostajeran 2006) that compared three
embryo transfer versus two embryo transfer were identified with
the new literature search but were excluded as the method of
randomisation was unclear in both trials.
The review has been converted into the new Rev man 5 format.
The order of appearance of the comparisons have been changed.
Two additional tables (1, 2) has been added.
8 May 2008 Amended Converted to new review format.




C O N T R I B U T I O N S   O F   A U T H O R S
Mohan S Kamath: checked the updated literature search, study selection, data extraction, quality assessment, entered and checked data,
completed the 'Risk of bias' tables and wrote the first draF of the review.
Mariano Mascarenhas: checked the updated literature search, study selection, data extraction, checked data and checked the draF.
Richard Kirubakaran: study selection, data extraction and data synthesis, 'Risk of bias' tables.
Siladitya Bhattacharya: study selection, quality assessment, responsible for final draF of the review.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
The structure of the comparisons was reformatted to prioritise comparisons of repeat single embryo transfer. Live birth and cumulative
live birth rates were amalgamated as a single primary outcome.
Studies of blastocyst transfer were added (previously only cleavage-stage transfers included).
At the 2020 update:
We planned subgroup analysis for the following prognostic factor: cleavage stage versus blastocyst stage transfer.
Sensitivity analysis: for the previous update, the planned sensitivity analysis restricted to studies at lower risk of bias (i.e. with clearly
reported methods of randomisation and allocation concealment and not at high risk of bias in any of the domains assessed); for the current
update, eligibility for lower risk of bias was restricted to studies without high or unclear risk of bias in any domain;
Risk of bias: in previous update, open label trials were categorised as unclear risk of bias for performance bias. For the current update,
we categorised studies at high risk of performance bias for lack of blinding. Awareness of group allotment is likely to influence clinicians
behaviour and performance; however, for detection bias we categorised them at low risk of bias since the outcomes were objective in
nature.
Measurement of treatment eIect: we used risk ratio instead of odds ratio for dichotomous outcomes as it is more intuitive and easier to
understand. However, we used Peto odds ratio for dichotomous outcomes that were associated with low events rate.
We have added two more clinical outcomes in the 'Summary of findings' tables (clinical pregnancy and miscarriage rates) for the current
update.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Blastocyst;  Cleavage Stage, Ovum  [transplantation];  Embryo Transfer  [*adverse eIects]  [*methods];  *Fertilization in Vitro; 
*Pregnancy Rate;  Pregnancy, Multiple;  Randomized Controlled Trials as Topic;  Sperm Injections, Intracytoplasmic
MeSH check words
Female; Humans; Pregnancy
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